| Company
| InsiderPie Expert Score
| P/E ratio
| Gross margin
| EBIT margin
| ROA
| Net income per employee
|
| Chongqing Pharscin Pharmaceutical Co., Ltd.
|
50
/ 100
| 101
| 57.6%
| 11.7%
| 3.7%
| €6.42K
|
| Integrated Cannabis Solutions, Inc.
|
50
/ 100
| 2.4
| 2.8%
| 1.0%
| 37.7%
| €1.84M
|
| RPG Life Sciences Limited
|
50
/ 100
| 20
| 66.7%
| 27.0%
| 0.0%
| €13.71K
|
| Bloomios, Inc.
|
50
/ 100
| -0.00016
| 25.0%
| -61.8%
| -2,086.3%
| -€11.53M
|
| Tibet Rhodiola Pharmaceutical Holding Co.
|
50
/ 100
| 12
| 93.3%
| 38.6%
| 16.9%
| €199.85K
|
| DrazCanna, Inc.
|
50
/ 100
| -0.0087
| -11.2%
| -275.2%
| -249.3%
| -€158.19K
|
| Kunming Longjin Pharmaceutical Co., Ltd.
|
50
/ 100
| -6.9
| 61.5%
| -98.2%
| -7.4%
| -€17.48K
|
| Dongwha Pharm.Co.,Ltd
|
50
/ 100
| 29
| 44.8%
| 1.2%
| 1.0%
| €4.57K
|
| Bora Pharmaceuticals Co., LTD.
|
50
/ 100
| 843
| 39.4%
| 10.6%
| 9.7%
| €0.00
|
| SAMSUNG PHARM. Co., Ltd.
|
50
/ 100
| 1.5
| 36.2%
| -34.9%
| 45.0%
| €248.25K
|
| Suven Pharmaceuticals Limited
|
50
/ 100
| 148
| 58.6%
| 31.9%
| 0.0%
| €22.28K
|
| Ascend Wellness Holdings, Inc.
|
50
/ 100
| -0.65
| 32.2%
| 1.0%
| -9.8%
| -€33.09K
|
| Mizuho Medy Co.,Ltd.
|
50
/ 100
| 8.9
| 71.1%
| 42.4%
| 16.7%
| €97.46K
|
| Tianjin Ringpu Bio-Technology Co.,Ltd.
|
50
/ 100
| 23
| 38.1%
| 12.6%
| 5.4%
| €20.34K
|
| Knight Therapeutics Inc.
|
50
/ 100
| 1.6K
| 42.9%
| -2.3%
| 0.0%
| €319.51
|
| Deciphera Pharmaceuticals, Inc.
|
50
/ 100
| -12
| 96.0%
| -118.1%
| -45.2%
| -€460.22K
|
| HLS Therapeutics Inc.
|
50
/ 100
| -5.6
| 82.6%
| -19.3%
| -10.1%
| -€140.30K
|
| DV Biomed Co., Ltd.
|
50
/ 100
| 86
| 73.8%
| 5.2%
| 2.1%
| €0.00
|
| Canzon Israel Ltd
|
50
/ 100
| -3.6
| 57.2%
| -407.5%
| -150.9%
| -€610.10K
|
| Tristar Wellness Solutions Inc.
|
50
/ 100
| -0.36
| 10.6%
| -114.0%
| -250.5%
| -€173.39K
|
| Cryomass Technologies Inc.
|
50
/ 100
| -0.74
| -59.9%
| -12,233.7%
| -780.6%
| -€1.26M
|
| Cannabotech LTD
|
50
/ 100
| -2
| -763.1%
| -3,610.3%
| -953.0%
| -€612.28K
|
| RxElite, Inc.
|
50
/ 100
| -0.000051
| 9.6%
| 100.5%
| -88.5%
| -€533.69K
|
| Strides Pharma Science Limited
|
50
/ 100
| 22
| 47.3%
| 14.7%
| 0.0%
| €11.28K
|
| Willow Biosciences Inc.
|
50
/ 100
| -1.1
| 105.5%
| -59.4%
| -179.3%
| -€135.68K
|
| Beijing Science Sun Pharmaceutical Co., Ltd.
|
50
/ 100
| 75
| 66.1%
| 19.5%
| 2.3%
| €18.53K
|
| HANDOK Inc.
|
50
/ 100
| -3.2
| 29.6%
| -1.3%
| -6.6%
| -€31.66K
|
| Nutranomics, Inc.
|
50
/ 100
| -0.52
| -50.0%
| -146.5%
| 0.0%
| -€2.54M
|
| PolyPeptide Group AG
|
50
/ 100
| -13
| 8.5%
| -4.6%
| -8.2%
| -€46.46K
|
| Amrutanjan Health Care Limited
|
50
/ 100
| 38
| 51.0%
| 17.1%
| 0.0%
| €8.20K
|
| Enzymatica AB (publ)
|
50
/ 100
| -14
| 66.1%
| -105.5%
| -34.3%
| -€230.43K
|
| CuraScientific Corp
|
50
/ 100
| 0.011
| -97.1%
| -622.6%
| 2,083.6%
| €14.45M
|
| Sequent Scientific Limited
|
50
/ 100
| 164
| 48.1%
| 12.2%
| 0.0%
| €2.37K
|
| Shandong Wohua Pharmaceutical Co., Ltd.
|
50
/ 100
| 51
| 73.7%
| 9.7%
| 6.7%
| €6.28K
|
| Yuhan Corporation
|
50
/ 100
| 99
| 34.0%
| 4.3%
| 2.6%
| €23.50K
|
| Dermapharm Holding SE
|
52
/ 100
| 18
| 65.7%
| 18.5%
| 5.0%
| €29.70K
|
| Avicanna Inc.
|
50
/ 100
| -22
| 54.2%
| -10.3%
| -6.3%
| -€9.15K
|
| Biofrontera AG
|
50
/ 100
| -17
| 80.6%
| 14.8%
| -1.2%
| -€4.05K
|
| Chengdu Kanghong Pharmaceutical Group Co., Ltd
|
50
/ 100
| 24
| 89.9%
| 30.8%
| 12.7%
| €34.02K
|
| AREV Life Sciences Global Corp.
|
50
/ 100
| -12
| -875.7%
| -2,919.0%
| -112.3%
| -€74.44K
|
| PharmaSGP Holding SE
|
50
/ 100
| 17
| 90.5%
| 23.1%
| 16.7%
| €216.55K
|
| Standard Chem & Pharm Co. Ltd.
|
50
/ 100
| 13
| 42.4%
| 19.5%
| 6.9%
| €19.54K
|
| Photocure ASA
|
50
/ 100
| -206
| 93.4%
| 0.2%
| -1.0%
| -€5.83K
|
| MPH Health Care AG
|
50
/ 100
| 20
| 116.1%
| 6.4%
| 1.9%
| €2.12M
|
| Shanghai Yizhong Pharmaceutical Co., Ltd.
|
50
/ 100
| 932
| 83.7%
| 11.1%
| 0.7%
| €3.39K
|
| Syncom Formulations (India) Limited
|
50
/ 100
| 35
| 35.0%
| 14.6%
| 0.0%
| €5.50K
|
| DIOD Maker of Eco-Friendly Equipment and Nutrition Public Joint Stock Company
|
50
/ 100
| 39
| 53.6%
| 2.4%
| 1.7%
| €0.00
|
| Choom Holdings Inc.
|
50
/ 100
| -0.15
| 37.7%
| -30.4%
| -81.9%
| -€249.38K
|
| Vencanna Ventures Inc.
|
50
/ 100
| -0.31
| 9.6%
| -16.8%
| -68.8%
| -€827.80K
|
| Procyon Corporation
|
50
/ 100
| -0.031
| 45.8%
| -4.6%
| -10.6%
| -€15.41K
|
| cbdMD, Inc.
|
50
/ 100
| -3.1
| 61.2%
| -9.4%
| -25.4%
| -€51.36K
|
| Maywufa Company Ltd.
|
50
/ 100
| 17
| 64.1%
| 13.8%
| 5.4%
| €16.96K
|
| Cann Group Limited
|
50
/ 100
| -0.11
| -36.1%
| -106.3%
| -93.4%
| -€1.05M
|
| Applied Biosciences Corp.
|
50
/ 100
| -0.001
| 61.4%
| -311.9%
| -81.5%
| -€95.64K
|
| PT Merck Tbk
|
50
/ 100
| 13
| 36.1%
| 15.8%
| 12.7%
| €17.51K
|
| Probi AB (publ)
|
50
/ 100
| 365
| 33.1%
| 0.4%
| 0.7%
| €6.33K
|
| C21 Investments Inc.
|
50
/ 100
| -3.7
| 42.1%
| 7.3%
| -5.9%
| -€24.96K
|
| Harrow Health, Inc.
|
50
/ 100
| -233
| 74.6%
| 11.1%
| -1.4%
| -€11.20K
|
| LiveWire Ergogenics, Inc.
|
50
/ 100
| 0.74
| 97.5%
| 45.2%
| 7.7%
| €523.65K
|
| Changzhou Qianhong Biopharma CO.,LTD
|
50
/ 100
| 27
| 57.8%
| 31.4%
| 14.2%
| €53.28K
|
| Terranueva Corporation
|
50
/ 100
| -1.2
| 40.5%
| -5.7%
| -52.8%
| €0.00
|
| Shenzhen Kangtai Biological Products Co., Ltd.
|
50
/ 100
| -167
| 76.3%
| -3.9%
| -0.7%
| -€6.36K
|
| Jiangsu Jibeier Pharmaceutical Co., Ltd.
|
50
/ 100
| 24
| 89.5%
| 26.1%
| 9.3%
| €22.56K
|
| Neurocrine Biosciences, Inc.
|
58
/ 100
| 29
| 98.4%
| 20.5%
| 10.0%
| €204.01K
|
| Supernus Pharmaceuticals, Inc.
|
48
/ 100
| 29
| 79.5%
| 9.5%
| 4.7%
| €82.10K
|
| Golden Developing Solutions, Inc.
|
50
/ 100
| -0.031
| 42.9%
| -67.5%
| -57.4%
| €0.00
|
| HLB Pharmaceutical Co., Ltd
|
50
/ 100
| 287K
| 63.9%
| 1.6%
| 3.6%
| €14.69K
|
| Guangdong Lifestrong Pharmacy Co., Ltd.
|
50
/ 100
| -143
| 71.6%
| -11.7%
| -2.0%
| -€3.31K
|
| Anhui Sunhere Pharmaceutical Excipients Co.,Ltd.
|
50
/ 100
| 23
| 30.7%
| 16.0%
| 8.0%
| €14.77K
|
| Ironwood Pharmaceuticals, Inc.
|
55
/ 100
| -17
| 99.7%
| 24.4%
| -2.0%
| -€23.58K
|
| Johnson Chemical Pharmaceutical Works Co., Ltd.
|
50
/ 100
| 38
| 40.5%
| 16.2%
| 4.1%
| €13.18K
|
| Lionco Pharmaceutical Group Co.,Ltd.
|
50
/ 100
| -30
| 35.4%
| -33.7%
| -10.4%
| -€35.11K
|
| Bod Science Limited
|
50
/ 100
| -0.38
| 3.0%
| -213.1%
| -485.3%
| €0.00
|
| Chalice Brands Ltd.
|
50
/ 100
| -1.7
| 42.0%
| -12.0%
| -11.4%
| €0.00
|
| Elite Pharmaceuticals, Inc.
|
50
/ 100
| -67
| 55.8%
| 35.5%
| -9.7%
| -€144.99K
|
| ShanXi C&Y Pharmaceutical Group Co., Ltd.
|
50
/ 100
| 132
| 67.3%
| 9.1%
| 1.3%
| €2.00K
|
| Cyfuse Biomedical K.K.
|
50
/ 100
| -6.7
| 21.9%
| -1,344.0%
| -24.1%
| -€213.00K
|
| Biofil Chemicals and Pharmaceuticals Limited
|
50
/ 100
| 30
| 6.1%
| 0.6%
| 0.0%
| €10.26K
|
| H. Lundbeck A/S
|
50
/ 100
| 9
| 81.5%
| 18.1%
| 6.7%
| €81.76K
|
| Pharmaxis Ltd
|
50
/ 100
| -1.1
| 10.4%
| -154.3%
| -88.9%
| -€152.50K
|
| Harbin Pharmaceutical Group Co., Ltd.
|
50
/ 100
| 22
| 26.6%
| 4.0%
| 3.2%
| €5.36K
|
| Lifecore Biomedical, Inc.
|
50
/ 100
| -6.5
| 31.3%
| -30.0%
| -16.2%
| -€63.40K
|
| Kangmei Pharmaceutical Co., Ltd.
|
50
/ 100
| 1.6K
| 18.2%
| 0.2%
| 0.1%
| €458.15
|
| Mega Lifesciences Public Company Limited
|
50
/ 100
| 12
| 52.5%
| 21.8%
| 13.0%
| €55.76K
|
| Yabao Pharmaceutical Group Co., Ltd
|
50
/ 100
| 20
| 52.0%
| 11.4%
| 6.7%
| €6.53K
|
| Little Green Pharma Ltd
|
50
/ 100
| -7.1
| 36.1%
| -32.9%
| -5.1%
| -€28.56K
|
| RedHill Biopharma Ltd.
|
50
/ 100
| -0.49
| 64.5%
| -110.4%
| -50.7%
| -€228.30K
|
| Zhejiang Jingxin Pharmaceutical Co., Ltd.
|
50
/ 100
| 16
| 49.1%
| 20.3%
| 8.9%
| €22.13K
|
| China Traditional Chinese Medicine Holdings Co. Limited
|
50
/ 100
| 15
| 48.8%
| 2.8%
| 1.9%
| €4.73K
|
| AB Science S.A.
|
50
/ 100
| -3.5
| 57.2%
| -1,004.9%
| -85.5%
| -€495.40K
|
| Unrivaled Brands, Inc.
|
50
/ 100
| -0.07
| 47.6%
| -8.3%
| -2.3%
| -€4.70K
|
| Kindred Biosciences, Inc.
|
50
/ 100
| 0
| 75.8%
| -508.1%
| -40.1%
| -€594.10K
|
| Zoetis Inc.
|
63
/ 100
| 28
| 71.0%
| 37.6%
| 17.5%
| €164.82K
|
| Heilongjiang ZBD Pharmaceutical Co., Ltd.
|
50
/ 100
| -334
| 50.8%
| -3.1%
| -0.3%
| -€1.59K
|
| Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
|
50
/ 100
| 40
| 32.0%
| 8.6%
| 2.5%
| €26.48K
|
| Shield Therapeutics plc
|
50
/ 100
| -0.0057
| 40.3%
| -78.8%
| -72.7%
| -€707.47K
|
| Chengdu Huasun Technology Group Inc., Ltd.
|
50
/ 100
| -35
| 51.5%
| -8.5%
| -3.4%
| -€10.01K
|
| Panacea Life Sciences Holdings, Inc.
|
50
/ 100
| 0.23
| 71.6%
| -64.1%
| 48.3%
| €70.68K
|
| Dong-A ST Co., Ltd.
|
50
/ 100
| -24
| 46.7%
| -1.8%
| -1.4%
| -€6.53K
|
| Black Bird Biotech, Inc.
|
50
/ 100
| -0.096
| 36.6%
| -866.0%
| -1,033.0%
| -€218.88K
|
| Greenway Greenhouse Cannabis Corporation
|
50
/ 100
| -15
| 26.3%
| -6.8%
| -5.2%
| €0.00
|
| Swedencare AB (publ)
|
50
/ 100
| 110
| 43.8%
| 6.4%
| 0.7%
| €9.80K
|
| Boiron SA
|
50
/ 100
| 9.3
| 73.3%
| 8.1%
| 7.7%
| €17.44K
|
| Zeria Pharmaceutical Co., Ltd.
|
50
/ 100
| 13
| 72.5%
| 11.5%
| 4.5%
| €21.15K
|
| KYORIN Holdings, Inc.
|
50
/ 100
| 7.7
| 45.8%
| 10.4%
| 5.4%
| €27.83K
|
| Beijing Tongrentang Co., Ltd
|
50
/ 100
| 38
| 44.1%
| 12.8%
| 4.3%
| €9.19K
|
| Aytu BioPharma, Inc.
|
50
/ 100
| -0.88
| 69.0%
| -11.8%
| -10.9%
| -€114.08K
|
| Moberg Pharma AB (publ)
|
50
/ 100
| -1.5
| 52.3%
| -2,624.6%
| -37.2%
| -€2.35M
|
| Sunflower Pharmaceutical Group Co.,Ltd
|
50
/ 100
| -73
| 30.3%
| -3.2%
| -2.5%
| -€2.72K
|
| AcuCort AB
|
50
/ 100
| -6.1
| 934.6%
| -2,884.0%
| -32.4%
| -€549.66K
|
| Shandong Xinhua Pharmaceutical Company Limited
|
50
/ 100
| 21
| 21.3%
| 5.9%
| 4.6%
| €7.13K
|
| Chong Kun Dang Holdings Corp.
|
50
/ 100
| 9.9
| 46.5%
| 4.5%
| 1.7%
| €410.97K
|
| PKU HealthCare Corp.,Ltd.
|
50
/ 100
| 25
| 26.1%
| 9.2%
| 6.8%
| €22.58K
|
| Unichem Laboratories Limited
|
50
/ 100
| 34
| 58.5%
| 14.3%
| 0.0%
| €4.34K
|
| GSRX Industries Inc.
|
50
/ 100
| -0.00095
| 48.4%
| -45.9%
| -154.8%
| €0.00
|
| BioAge Labs, Inc.
|
50
/ 100
| -2.4
| 60.9%
| -2,364.2%
| -24.5%
| -€1.09M
|
| LanZhou Foci Pharmaceutical Co.,Ltd.
|
50
/ 100
| 76
| 30.8%
| 7.0%
| 2.3%
| €5.30K
|
| Elixinol Wellness Limited
|
50
/ 100
| -0.36
| 26.7%
| -31.8%
| -53.8%
| €0.00
|
| Vivimed Labs Limited
|
50
/ 100
| -0.89
| 35.5%
| -15.8%
| 0.0%
| -€7.27K
|
| Sunniva Inc.
|
50
/ 100
| -0.12
| 27.8%
| -104.2%
| -38.5%
| €0.00
|
| China Animal Husbandry Industry Co., Ltd.
|
50
/ 100
| 34
| 16.2%
| 1.8%
| 2.3%
| €6.06K
|
| Hypera S.A.
|
50
/ 100
| 124
| 56.1%
| 7.1%
| 3.1%
| €11.22K
|
| Aurora Cannabis Inc.
|
50
/ 100
| -22
| 39.3%
| -12.5%
| -2.4%
| -€11.66K
|
| Curaleaf Holdings, Inc.
|
50
/ 100
| -0.97
| 39.6%
| -4.9%
| -14.9%
| -€73.23K
|
| Biofrontera Inc.
|
50
/ 100
| -0.37
| 61.7%
| -41.6%
| -82.4%
| -€154.74K
|
| Lowell Farms Inc.
|
50
/ 100
| -0.0079
| -49.3%
| -92.5%
| -72.9%
| -€185.21K
|
| The Cannabist Company Holdings Inc.
|
50
/ 100
| -0.15
| 32.3%
| -11.3%
| -29.5%
| -€85.01K
|
| Cannabis Bioscience International Holdings, Inc.
|
50
/ 100
| -12
| 73.1%
| -263.4%
| -2,990.0%
| -€242.97K
|
| Beijing Aosaikang Pharmaceutical Co., Ltd.
|
50
/ 100
| 69
| 79.8%
| 12.2%
| 5.8%
| €31.82K
|
| Hunan Hansen Pharmaceutical Co., Ltd.
|
50
/ 100
| 19
| 77.1%
| 22.2%
| 6.7%
| €13.59K
|
| Diurnal Group plc
|
50
/ 100
| 0
| 87.9%
| -267.4%
| -39.0%
| -€283.42K
|
| Lasa Supergenerics Limited
|
50
/ 100
| -2
| 24.2%
| -5.4%
| 0.0%
| -€41.02K
|
| Changjiang Pharmaceutical Group Co., Ltd.
|
50
/ 100
| -2.5
| -6.5%
| -745.0%
| -34.1%
| -€226.48K
|
| Ortin Laboratories Limited
|
50
/ 100
| -2.1
| -88.2%
| -319.9%
| -120.7%
| -€31.93K
|
| Haleon plc
|
50
/ 100
| 0.24
| 61.8%
| 20.5%
| 4.8%
| €70.85K
|
| WOWI, Inc.
|
50
/ 100
| -0.19
| 100.0%
| -62.2%
| -2.7%
| €0.00
|
| Cannara Biotech Inc.
|
50
/ 100
| 8.1
| 44.2%
| 20.6%
| 7.8%
| €17.63K
|
| Bal Pharma Limited
|
50
/ 100
| 22
| 42.3%
| 6.5%
| 0.0%
| €785.74
|
| Planet 13 Holdings Inc.
|
50
/ 100
| -0.76
| 41.7%
| 30.1%
| -56.0%
| -€76.15K
|
| Marijuana Company of America, Inc.
|
50
/ 100
| -0.0041
| -708.5%
| -3,037.9%
| 0.0%
| -€588.47K
|
| Body and Mind Inc.
|
50
/ 100
| -0.16
| 40.9%
| -39.7%
| -101.5%
| -€99.31K
|
| AstraZeneca Pharma India Limited
|
50
/ 100
| 139
| 44.6%
| 13.2%
| 0.0%
| €18.59K
|
| PharmaEssentia Corporation
|
50
/ 100
| 52
| 88.2%
| 27.5%
| 12.3%
| €0.00
|
| Anhui Fengyuan Pharmaceutical Co., Ltd.
|
50
/ 100
| 26
| 17.8%
| 3.0%
| 2.3%
| €3.04K
|
| The Greater Cannabis Company, Inc.
|
50
/ 100
| -0.51
| 50.0%
| -3,336.5%
| -2,687.0%
| -€492.33K
|
| iAnthus Capital Holdings, Inc.
|
50
/ 100
| 7.4
| 46.2%
| -6.8%
| 1.0%
| €3.10K
|
| Humedix Co., Ltd.
|
50
/ 100
| 15
| 47.2%
| 26.4%
| 14.7%
| €102.19K
|
| Apontis Pharma AG
|
50
/ 100
| -14
| 15.0%
| -10.5%
| -14.6%
| -€46.89K
|
| 1933 Industries Inc.
|
50
/ 100
| -4.7
| 16.3%
| 12.6%
| -3.2%
| -€3.83K
|
| Hemp, Inc
|
50
/ 100
| -0.019
| -101.7%
| -2,554.4%
| 0.0%
| -€163.45K
|
| THC Biomed Intl Ltd.
|
50
/ 100
| -1.7
| -57.5%
| -120.1%
| 0.0%
| -€34.22K
|
| NxGen Brands Inc.
|
50
/ 100
| -0.22
| -33.7%
| -256.5%
| -128.9%
| €0.00
|
| Wanbury Limited
|
50
/ 100
| 23
| 51.8%
| 11.8%
| 0.0%
| €2.75K
|
| Eagle Pharmaceuticals, Inc.
|
50
/ 100
| 1.9
| 69.8%
| 9.2%
| 3.8%
| €99.67K
|
| Vitura Health Limited
|
50
/ 100
| 6.5
| 23.6%
| 4.1%
| 9.1%
| €0.00
|
| Next Science Limited
|
50
/ 100
| -0.36
| 78.7%
| -50.6%
| -221.1%
| €0.00
|
| Northeast Pharmaceutical Group Co., Ltd.
|
50
/ 100
| 20
| 39.5%
| 7.4%
| 2.7%
| €7.32K
|
| Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD
|
50
/ 100
| 113
| 68.5%
| 10.5%
| 2.1%
| €5.37K
|
| Jiangsu Kanion Pharmaceutical Co.,Ltd.
|
50
/ 100
| 41
| 69.4%
| 6.2%
| 3.5%
| €5.23K
|
| Alembic Limited
|
50
/ 100
| 9.7
| 69.0%
| 37.1%
| 0.0%
| €105.82K
|
| TerrAscend Corp.
|
50
/ 100
| -3.4
| 50.5%
| -5.7%
| -20.6%
| -€106.53K
|
| China National Medicines Corporation Ltd.
|
50
/ 100
| 12
| 6.6%
| 4.8%
| 5.7%
| €78.65K
|
| Tsumura & Co.
|
50
/ 100
| 10
| 48.9%
| 20.6%
| 5.5%
| €34.15K
|
| Cipher Pharmaceuticals Inc.
|
50
/ 100
| 15
| 73.8%
| 24.4%
| 8.0%
| €2.08M
|
| Redwood Scientific Technologies, Inc.
|
50
/ 100
| -0.0024
| 83.6%
| -994.6%
| -1,633.7%
| -€831.13K
|
| Livzon Pharmaceutical Group Inc.
|
50
/ 100
| 15
| 65.9%
| 25.0%
| 8.7%
| €28.68K
|
| ApicHope Pharmaceutical Co., Ltd
|
50
/ 100
| -61
| 53.4%
| -56.4%
| -9.5%
| -€35.14K
|
| Glenmark Pharmaceuticals Limited
|
50
/ 100
| 62
| 60.8%
| 14.2%
| 0.0%
| €4.79K
|
| Jinling Pharmaceutical Company Limited
|
50
/ 100
| 117
| 18.8%
| 1.0%
| 0.6%
| €786.34
|
| Kali, Inc.
|
50
/ 100
| 0.00064
| 43.2%
| 25.8%
| 22.8%
| €103.35K
|
| Daewoong pharmaceutical Co.,Ltd
|
50
/ 100
| 25
| 51.7%
| 11.6%
| 3.6%
| €25.45K
|
| Divi's Laboratories Limited
|
50
/ 100
| 78
| 55.7%
| 27.5%
| 0.0%
| €22.56K
|
| Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd
|
50
/ 100
| 27
| 41.9%
| 22.5%
| 7.3%
| €59.18K
|
| CannaPharmaRX, Inc.
|
50
/ 100
| -0.47
| -233.0%
| -259.2%
| -49.3%
| -€186.68K
|
| Acorda Therapeutics, Inc.
|
50
/ 100
| -0.0031
| 79.7%
| -21.0%
| -322.9%
| -€2.22M
|
| North China Pharmaceutical Company Ltd.
|
50
/ 100
| 56
| 31.2%
| 4.4%
| 0.8%
| €2.19K
|
| Catalent, Inc.
|
50
/ 100
| -28
| 21.8%
| 1.3%
| -4.3%
| -€20.84K
|
| Pacira BioSciences, Inc.
|
50
/ 100
| 53
| 77.2%
| 5.8%
| 1.7%
| €23.34K
|
| Eris Lifesciences Limited
|
50
/ 100
| 60
| 68.5%
| 33.0%
| 0.0%
| €10.19K
|
| Venture Life Group plc
|
50
/ 100
| 1.1
| 37.2%
| 6.8%
| 0.5%
| €4.21K
|
| Sigachi Industries Limited
|
50
/ 100
| -44
| 48.2%
| 16.5%
| 0.0%
| -€4.23K
|
| Alpha Teknova, Inc.
|
50
/ 100
| -15
| 23.7%
| -55.0%
| -19.5%
| -€106.63K
|
| Agile Therapeutics, Inc.
|
50
/ 100
| -0.66
| 63.6%
| -62.8%
| -106.0%
| -€716.07K
|
| Tianjin Tianyao Pharmaceuticals Co., Ltd.
|
50
/ 100
| 289
| 42.7%
| 5.8%
| 0.3%
| €738.64
|
| Vibe Growth Corporation
|
50
/ 100
| -0.059
| 37.9%
| -10.2%
| -51.9%
| €0.00
|
| Ind-Swift Laboratories Limited
|
50
/ 100
| 2.6
| 51.0%
| 1.9%
| 0.0%
| €523.71K
|
| Delta 9 Cannabis Inc.
|
50
/ 100
| -0.077
| 7.5%
| -25.9%
| -27.9%
| -€60.90K
|
| Sakar Healthcare Limited
|
50
/ 100
| 35
| 36.0%
| 16.0%
| 0.0%
| €5.79K
|
| Shionogi & Co., Ltd.
|
50
/ 100
| 12
| 85.5%
| 37.5%
| 11.6%
| €199.44K
|
| Zhejiang Shengda Bio-Pharm Co., Ltd.
|
50
/ 100
| 55
| 25.0%
| 9.4%
| 2.4%
| €5.97K
|
| Glenmark Life Sciences Limited
|
50
/ 100
| 30
| 51.5%
| 26.0%
| 0.0%
| €21.15K
|
| Dr. Reddy's Laboratories Limited
|
55
/ 100
| 20
| 57.7%
| 21.4%
| 10.9%
| €20.01K
|
| Pacific Shuanglin Bio-pharmacy Co., Ltd.
|
50
/ 100
| 32
| 46.1%
| 27.6%
| 5.8%
| €25.79K
|
| Zydus Lifesciences Limited
|
50
/ 100
| 33
| 47.0%
| 22.4%
| 0.0%
| €10.53K
|
| Quick-Med Technologies, Inc.
|
50
/ 100
| -0.0052
| 69.8%
| -40.5%
| -98.6%
| -€122.36K
|
| Hainan Haiyao Co., Ltd.
|
50
/ 100
| -5.7
| 28.3%
| -177.5%
| -25.4%
| -€89.23K
|
| LIWANLI Innovation Co., Ltd.
|
50
/ 100
| -74
| 26.4%
| -43.2%
| -3.3%
| -€1.98K
|
| Earth Science Tech, Inc.
|
50
/ 100
| 16
| 72.0%
| 10.2%
| 34.0%
| €70.85K
|
| TSH Biopharm Corporation Limited
|
50
/ 100
| 19
| 51.2%
| 15.6%
| 6.2%
| €39.45K
|
| Bafna Pharmaceuticals Limited
|
50
/ 100
| 21
| 27.9%
| 6.9%
| 0.0%
| €2.17K
|
| Benchmark Holdings plc
|
50
/ 100
| 0.039
| 47.8%
| -79.1%
| 10.8%
| €65.74K
|
| Renhe Pharmacy Co., Ltd.
|
50
/ 100
| 18
| 37.0%
| 18.8%
| 5.5%
| €9.12K
|
| ECO Animal Health Group plc
|
50
/ 100
| 0.16
| 43.5%
| 4.6%
| 2.3%
| €13.77K
|
| Kwang Dong Pharmaceutical Co., Ltd.
|
50
/ 100
| 8.5
| 17.5%
| 1.0%
| 2.3%
| €15.31K
|
| Medical Marijuana, Inc.
|
50
/ 100
| -2.7
| 77.7%
| 3.4%
| -0.6%
| -€3.95K
|
| Dong Sung Bio Pharm.Co.,Ltd.
|
50
/ 100
| -2.5
| 43.4%
| -9.0%
| -17.7%
| -€51.30K
|
| Medico Remedies Limited
|
50
/ 100
| 38
| 28.3%
| 11.6%
| 0.0%
| €5.10K
|
| Nectar Lifesciences Limited
|
50
/ 100
| -3
| 12.4%
| -12.0%
| 0.0%
| -€10.17K
|
| Item 9 Labs Corp.
|
50
/ 100
| -0.0023
| 49.8%
| -102.4%
| -27.7%
| -€274.34K
|
| PT Darya-Varia Laboratoria Tbk
|
50
/ 100
| 12
| 53.9%
| 10.2%
| 6.6%
| €6.28K
|
| Tibet Weixinkang Medicine Co., Ltd.
|
50
/ 100
| 18
| 57.8%
| 27.5%
| 14.1%
| €46.78K
|
| Sun Pharma Advanced Research Company Limited
|
50
/ 100
| -18
| -49.7%
| -434.3%
| 0.0%
| -€69.54K
|
| Mayinglong Pharmaceutical Group Co., Ltd.
|
50
/ 100
| 22
| 47.5%
| 18.1%
| 10.7%
| €24.08K
|
| AcelRx Pharmaceuticals, Inc.
|
50
/ 100
| -0.48
| -649.9%
| 5,398.0%
| -133.5%
| -€995.64K
|
| Tianjin Lisheng Pharmaceutical Co.,Ltd.
|
50
/ 100
| 13
| 56.9%
| 34.8%
| 6.5%
| €29.21K
|
| Tianjin Chase Sun Pharmaceutical Co.,Ltd
|
50
/ 100
| -169
| 52.8%
| -0.1%
| -0.6%
| -€1.52K
|
| Intra-Cellular Therapies, Inc.
|
50
/ 100
| -188
| 91.6%
| -17.1%
| -5.5%
| -€74.50K
|
| Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
|
50
/ 100
| 14
| 16.6%
| 4.7%
| 3.6%
| €12.88K
|
| Huons Co., Ltd.
|
50
/ 100
| 9.7
| 47.4%
| 7.7%
| 5.5%
| €22.44K
|
| Aoxing Pharmaceutical Company, Inc.
|
50
/ 100
| -0.39
| 76.2%
| 3.2%
| -2.3%
| -€3.63K
|
| Bhang Inc.
|
50
/ 100
| -0.26
| 68.6%
| -284.4%
| -528.8%
| €0.00
|
| Zhejiang Cheng Yi Pharmaceutical Co., Ltd.
|
50
/ 100
| 13
| 69.6%
| 34.1%
| 14.0%
| €38.93K
|
| RAMM Pharma Corp.
|
50
/ 100
| -0.17
| 36.8%
| -135.7%
| -88.1%
| €0.00
|
| Orchid Pharma Limited
|
50
/ 100
| 43
| 42.1%
| 18.5%
| 0.0%
| €9.32K
|
| ZhuZhou QianJin Pharmaceutical Co.,Ltd
|
50
/ 100
| 18
| 49.2%
| 9.8%
| 5.1%
| €5.69K
|
| Verano Holdings Corp.
|
50
/ 100
| -3.8
| 50.7%
| -29.0%
| -17.8%
| -€76.11K
|
| Real Brands, Inc.
|
50
/ 100
| -0.37
| -29.6%
| -750.2%
| -60.8%
| -€627.86K
|
| Sweet Earth Holdings Corporation
|
50
/ 100
| 24
| 143,100.0%
| 4,269,700.0%
| 1,025.4%
| €0.00
|
| Allergy Therapeutics plc
|
50
/ 100
| -0.04
| 53.3%
| -64.2%
| -117.7%
| -€160.42K
|
| Ajanta Pharma Limited
|
50
/ 100
| 37
| 77.6%
| 50.8%
| 0.0%
| €10.98K
|
| Taisho Pharmaceutical Holdings Co., Ltd.
|
50
/ 100
| 84
| 57.2%
| 5.9%
| 0.8%
| €5.29K
|
| Hunan Warrant Pharmaceutical Co.,Ltd
|
50
/ 100
| 57
| 60.7%
| 8.4%
| 4.9%
| €12.03K
|
| Pharmanutra S.p.A.
|
50
/ 100
| 28
| 74.3%
| 23.7%
| 14.6%
| €143.19K
|
| Torii Pharmaceutical Co., Ltd.
|
50
/ 100
| 32
| 40.7%
| 11.5%
| 4.1%
| €51.76K
|
| Albert David Limited
|
50
/ 100
| 78
| 66.0%
| 4.1%
| 0.0%
| €400.63
|
| Silo Wellness Inc.
|
50
/ 100
| 0.13
| 51.2%
| -290.8%
| 8,963.9%
| €0.00
|
| Granules India Limited
|
50
/ 100
| 27
| 57.8%
| 15.4%
| 0.0%
| €11.26K
|
| Invion Limited
|
50
/ 100
| -0.7
| -7.8%
| -315.6%
| -152.1%
| -€1.03M
|
| Green Cures & Botanical Distribution Inc.
|
50
/ 100
| 3.4
| 48.3%
| 8.3%
| 7.5%
| €6.56K
|
| Henan Taloph Pharmaceutical Stock Co.,Ltd
|
50
/ 100
| 72
| 24.0%
| 3.4%
| 1.3%
| €2.57K
|
| Ildong Holdings Co., Ltd.
|
50
/ 100
| 1.6
| 36.1%
| 1.1%
| 5.9%
| €365.50K
|
| Green Scientific Labs Holdings Inc.
|
50
/ 100
| -0.042
| 50.4%
| -217.5%
| -203.4%
| €0.00
|
| Jubilant Pharmova Limited
|
50
/ 100
| 40
| 58.9%
| 11.3%
| 0.0%
| €8.12K
|
| Ningbo Menovo Pharmaceutical Co., Ltd.
|
50
/ 100
| 39
| 33.8%
| 9.0%
| 2.1%
| €5.00K
|
| Hunan Fangsheng Pharmaceutical Co., Ltd.
|
50
/ 100
| 17
| 70.7%
| 18.7%
| 9.4%
| €20.71K
|
| InterCure Ltd.
|
50
/ 100
| -15
| 17.6%
| -28.1%
| -8.9%
| -€56.67K
|
| Tien Liang BioTech Co., Ltd.
|
50
/ 100
| -67
| 57.9%
| 0.1%
| -2.2%
| -€10.53K
|
| Khiron Life Sciences Corp.
|
50
/ 100
| -2.6
| 26.2%
| -118.9%
| -9.3%
| €0.00
|
| Shanghai Haoyuan Chemexpress Co., Ltd.
|
50
/ 100
| 37
| 49.6%
| 13.6%
| 4.8%
| €9.60K
|
| The CannaBusiness Group, Inc.
|
50
/ 100
| -0.00048
| 37.0%
| -17.9%
| -39.7%
| €0.00
|
| Amneal Pharmaceuticals, Inc.
|
50
/ 100
| 615
| 36.8%
| 9.8%
| 0.2%
| €609.90
|
| Ovation Science Inc.
|
50
/ 100
| -3.9
| 90.1%
| -660.1%
| -1,161.4%
| €0.00
|
| Amexdrug Corporation
|
50
/ 100
| 293
| 16.6%
| 5.0%
| 2.5%
| €5.52
|
| Next Generation Management Corp.
|
50
/ 100
| -0.056
| 100.0%
| -2,596.8%
| -2,072.4%
| -€1.54M
|
| Golden Biotechnology Corporation
|
50
/ 100
| -3.3
| -25.7%
| -667.4%
| -127.0%
| -€173.55K
|
| Rua Bioscience Limited
|
50
/ 100
| -0.35
| -75.9%
| -350.7%
| -253.6%
| €0.00
|
| Enzychem Lifesciences Corporation
|
50
/ 100
| -4.1
| 4.9%
| -18.7%
| -13.2%
| -€108.32K
|
| CanSino Biologics Inc.
|
50
/ 100
| -60
| 69.6%
| -23.3%
| -2.2%
| -€18.35K
|
| Jiuzhitang Co., Ltd.
|
50
/ 100
| 66
| 59.6%
| 7.9%
| 2.5%
| €4.40K
|
| ScinoPharm Taiwan, Ltd.
|
50
/ 100
| 68
| 37.7%
| 6.8%
| 1.7%
| €5.57K
|
| ZIM Laboratories Limited
|
50
/ 100
| 55
| 56.2%
| 5.4%
| 0.0%
| €1.61K
|
| Sunshine Biopharma, Inc.
|
50
/ 100
| -1.3
| 33.6%
| -17.9%
| -19.7%
| -€104.06K
|
| Jupiter Wellness, Inc.
|
50
/ 100
| -9.2
| 27.8%
| 1,656.5%
| -5.1%
| -€184.89K
|
| Teyi Pharmaceutical Group Co.,Ltd
|
50
/ 100
| 82
| 54.8%
| 8.2%
| 2.5%
| €5.45K
|
| Orexo AB (publ)
|
50
/ 100
| -31
| 87.3%
| -26.1%
| -40.1%
| -€177.51K
|
| Alpa Laboratories Limited
|
50
/ 100
| 8.1
| 28.2%
| 2.2%
| 0.0%
| €6.10K
|
| Ionic Brands Corp.
|
50
/ 100
| -0.039
| 8.2%
| -42.0%
| -35.0%
| -€170.87K
|
| Acerus Pharmaceuticals Corporation
|
50
/ 100
| -0.046
| 56.3%
| -786.4%
| -67.7%
| -€1.98M
|
| Medexus Pharmaceuticals Inc.
|
50
/ 100
| 62
| 52.5%
| 4.8%
| 0.5%
| €8.43K
|
| Yuyu Pharma, Inc.
|
50
/ 100
| 15
| 38.3%
| 7.0%
| 2.5%
| €11.78K
|
| Advantis Corp.
|
50
/ 100
| -0.27
| -36.3%
| -1,807.7%
| -2.8%
| -€62.37K
|
| Shenzhen Chipscreen Biosciences Co., Ltd.
|
50
/ 100
| -216
| 86.3%
| -14.8%
| -1.3%
| -€5.05K
|
| REYON Pharmaceutical Co., Ltd.
|
50
/ 100
| -21
| 37.6%
| -10.8%
| -2.1%
| -€12.75K
|
| Center Laboratories, Inc.
|
50
/ 100
| -42
| 44.0%
| 11.6%
| -2.8%
| -€100.87K
|
| Yooma Wellness Inc.
|
50
/ 100
| -0.0091
| 25.3%
| -199.9%
| -95.7%
| €0.00
|
| Hybio Pharmaceutical Co., Ltd.
|
50
/ 100
| -181
| 58.2%
| -1.7%
| -2.1%
| -€9.15K
|
| Shin Poong Pharm.Co.,Ltd.
|
50
/ 100
| -49
| 40.2%
| -4.0%
| -3.2%
| -€7.72K
|
| Alkem Laboratories Limited
|
50
/ 100
| 25
| 63.5%
| 17.1%
| 0.0%
| €12.49K
|
| Nippon Shinyaku Co., Ltd.
|
50
/ 100
| 1.3K
| 68.2%
| 23.1%
| 10.5%
| €76.15K
|
| Hainan Shuangcheng Pharmaceuticals Co., Ltd.
|
50
/ 100
| -76
| 53.9%
| -28.3%
| -5.4%
| -€11.01K
|
| Winston Medical Supply Co., Ltd.
|
50
/ 100
| 7.2
| 46.1%
| 24.5%
| 33.1%
| €0.00
|
| Celltrion Pharm, Inc.
|
50
/ 100
| 67
| 28.1%
| 9.9%
| 4.5%
| €21.68K
|
| FDC Limited
|
50
/ 100
| 28
| 53.2%
| 12.0%
| 0.0%
| €3.85K
|
| Zhejiang Medicine Co., Ltd.
|
50
/ 100
| 12
| 40.5%
| 14.4%
| 8.8%
| €24.25K
|
| Shanxi Zhendong Pharmaceutical Co.,Ltd
|
50
/ 100
| -3.4
| 48.9%
| -25.2%
| -29.9%
| -€45.77K
|
| MariMed Inc.
|
50
/ 100
| -1.8
| 38.6%
| 0.1%
| -7.8%
| -€19.12K
|
| Evolus, Inc.
|
50
/ 100
| -10
| 66.7%
| -15.6%
| -27.1%
| -€142.99K
|
| Jushi Holdings Inc.
|
50
/ 100
| -0.71
| 42.2%
| 0.0%
| -13.4%
| -€40.21K
|
| Grape King Bio Ltd
|
50
/ 100
| 15
| 76.8%
| 21.7%
| 9.0%
| €73.55K
|
| Krebs Biochemicals & Industries Limited
|
50
/ 100
| -7.3
| 87.2%
| -59.9%
| 0.0%
| -€13.52K
|
| Link Reservations Inc.
|
50
/ 100
| -0.25
| -1.1%
| -7.9%
| -47.8%
| €0.00
|
| Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd
|
50
/ 100
| 26
| 55.0%
| 13.4%
| 5.1%
| €16.97K
|
| Indoco Remedies Limited
|
50
/ 100
| -23
| 54.8%
| -2.8%
| 0.0%
| -€1.78K
|
| Zhejiang Hisun Pharmaceutical Co., Ltd.
|
50
/ 100
| 21
| 47.8%
| 7.8%
| 3.6%
| €8.23K
|
| Creative Edge Nutrition, Inc.
|
50
/ 100
| -0.28
| 80.9%
| -193.1%
| -125.6%
| €0.00
|
| NeutriSci International Inc.
|
50
/ 100
| -1.6
| -43.9%
| -841.4%
| -432.4%
| €0.00
|
| Aspen Pharmacare Holdings Limited
|
50
/ 100
| 99
| 45.2%
| 13.8%
| 6.8%
| €53.31K
|
| Shineco, Inc.
|
50
/ 100
| -0.24
| 6.9%
| -143.5%
| -45.5%
| -€280.51K
|
| Imagenetix, Inc.
|
50
/ 100
| -0.00077
| 66.4%
| -30.4%
| -41.4%
| -€634.61K
|
| Filament Health Corp.
|
50
/ 100
| -0.79
| 82.6%
| -595.1%
| -145.7%
| -€237.63K
|
| GeneFerm Biotechnology Co., Ltd.
|
50
/ 100
| -2.6K
| 22.9%
| 0.5%
| -0.1%
| €0.00
|
| Theratechnologies Inc.
|
50
/ 100
| -9.4
| 77.7%
| 8.4%
| -17.9%
| -€76.28K
|
| SCYNEXIS, Inc.
|
47
/ 100
| -1.8
| 58.1%
| -1,121.7%
| -32.2%
| -€598.06K
|
| Canntab Therapeutics Limited
|
50
/ 100
| -0.13
| 98.3%
| 16,593.7%
| 0.0%
| €0.00
|
| BNC Korea Co., Ltd.
|
50
/ 100
| 46K
| 47.6%
| 13.7%
| 5.8%
| €43.23K
|
| Avivagen Inc.
|
50
/ 100
| -0.17
| 42.7%
| -333.2%
| -1,702.5%
| -€221.82K
|
| Sun Pharmaceutical Industries Limited
|
50
/ 100
| 39
| 73.8%
| 32.1%
| 0.0%
| €22.98K
|
| EuBiologics Co., Ltd.
|
50
/ 100
| 9.9
| 56.1%
| 41.5%
| 21.3%
| €86.50K
|
| Ilsung Pharmaceuticals Co., Ltd.
|
50
/ 100
| 14
| 41.8%
| -9.3%
| 3.0%
| €30.31K
|
| BioDelivery Sciences International, Inc.
|
50
/ 100
| 6.8
| 86.0%
| 22.3%
| 26.1%
| €364.05K
|
| Lifeist Wellness Inc.
|
50
/ 100
| 4.3
| -187.4%
| -201.0%
| 23.8%
| €5.32K
|
| KPC Pharmaceuticals, Inc.
|
50
/ 100
| 22
| 42.8%
| 9.2%
| 4.4%
| €12.20K
|
| PLx Pharma Inc.
|
50
/ 100
| -0.17
| 4.5%
| -880.5%
| -45.6%
| -€812.13K
|
| Fagron NV
|
50
/ 100
| 9.8
| 33.9%
| 15.0%
| 14.6%
| €42.74K
|
| Almirall, S.A.
|
50
/ 100
| 110
| 78.1%
| 4.9%
| 0.9%
| €10.53K
|
| MedMen Enterprises Inc.
|
50
/ 100
| -0.00065
| 50.2%
| -23.8%
| -70.9%
| -€306.37K
|
| Summerway Capital Plc
|
50
/ 100
| -0.019
| 30.0%
| 758.1%
| -61.8%
| -€221.56K
|
| SLANG Worldwide Inc.
|
50
/ 100
| -0.036
| 45.1%
| -28.8%
| -139.4%
| -€130.04K
|
| Hubei Jumpcan Pharmaceutical Co., Ltd.
|
50
/ 100
| 16
| 77.3%
| 31.2%
| 10.0%
| €38.33K
|
| Mystic Holdings, Inc.
|
50
/ 100
| -0.78
| 61.4%
| -29.6%
| -16.5%
| -€63.84K
|
| LFTD Partners Inc.
|
50
/ 100
| 0
| 32.2%
| -2.4%
| -4,807,091.5%
| -€23.17B
|
| AFT Pharmaceuticals Limited
|
50
/ 100
| 10
| 44.6%
| 10.4%
| 16.2%
| €124.51K
|
| Walvax Biotechnology Co., Ltd.
|
50
/ 100
| 333
| 74.2%
| -6.5%
| 0.4%
| €2.50K
|
| Saudi Pharmaceutical Industries and Medical Appliances Corporation
|
50
/ 100
| 51
| 48.3%
| 11.0%
| 1.5%
| €49.40K
|
| Medicamen Biotech Limited
|
50
/ 100
| 64
| 43.3%
| 4.9%
| 0.0%
| €2.26K
|
| Recro Pharma, Inc.
|
50
/ 100
| -8.7
| 20.1%
| -1.9%
| -8.6%
| -€61.56K
|
| Hempsana Holdings Ltd.
|
50
/ 100
| -0.4
| 31.2%
| -96.1%
| -34.1%
| €0.00
|
| Novartis India Limited
|
50
/ 100
| 24
| 42.7%
| 28.7%
| 0.0%
| €157.95K
|
| Can B Corp.
|
50
/ 100
| -0.13
| -167.5%
| -978.0%
| -654.4%
| -€868.53K
|
| Sichuan Huiyu Pharmaceutical Co., Ltd.
|
50
/ 100
| 42
| 82.2%
| 17.4%
| 3.7%
| €15.76K
|
| Parenteral Drugs (India) Ltd.
|
50
/ 100
| -0.13
| 35.7%
| -34.1%
| -15.8%
| -€8.00K
|
| Beijing Beilu Pharmaceutical Co., Ltd
|
50
/ 100
| 132
| 44.6%
| 1.4%
| 1.0%
| €3.46K
|
| JW Lifescience Corporation
|
50
/ 100
| 3.9
| 27.2%
| 15.4%
| 15.8%
| €96.21K
|
| Celon Pharma S.A.
|
50
/ 100
| -18
| 62.6%
| -24.6%
| -14.2%
| -€28.85K
|
| Chong Kun Dang Pharmaceutical Corp.
|
50
/ 100
| 19
| 31.2%
| 4.1%
| 4.1%
| €15.68K
|
| Rockwell Medical, Inc.
|
50
/ 100
| -6.1
| 15.1%
| -6.4%
| -9.6%
| -€19.40K
|
| Chill Brands Group PLC
|
50
/ 100
| -0.016
| -6.2%
| -279.8%
| -313.5%
| -€1.09M
|
| Mochida Pharmaceutical Co., Ltd.
|
50
/ 100
| 18
| 51.2%
| 8.0%
| 3.7%
| €21.84K
|
| Tibet AIM Pharm. Inc.
|
50
/ 100
| 51
| 80.3%
| 12.7%
| 8.1%
| €23.75K
|
| Kaya Holdings, Inc.
|
50
/ 100
| -0.12
| -585.7%
| 74,744.5%
| -5,893.7%
| -€5.04M
|
| Formosa Laboratories, Inc.
|
50
/ 100
| -137
| 41.6%
| 15.5%
| -0.4%
| -€1.93K
|
| Hanmi Pharm. Co., Ltd.
|
50
/ 100
| 36
| 40.2%
| 13.7%
| 5.6%
| €28.20K
|
| Aarti Drugs Limited
|
50
/ 100
| 23
| 34.1%
| 15.2%
| 0.0%
| €16.91K
|
| Althea Group Holdings Limited
|
50
/ 100
| -0.58
| 19.9%
| -32.6%
| -180.6%
| €0.00
|
| Themis Medicare Limited
|
50
/ 100
| -146
| 55.3%
| 8.9%
| 0.0%
| -€572.83
|
| Guizhou Bailing Group Pharmaceutical Co., Ltd.
|
50
/ 100
| 2.6K
| 54.0%
| 1.5%
| 0.0%
| €40.95
|
| Towa Pharmaceutical Co., Ltd.
|
50
/ 100
| 9.4
| 36.3%
| 8.7%
| 3.4%
| €19.24K
|
| HUTCHMED (China) Limited
|
50
/ 100
| 6.7
| 8.9%
| -3.3%
| 26.3%
| €221.20K
|
| Suven Life Sciences Limited
|
50
/ 100
| -31
| -139.0%
| -2,550.2%
| 0.0%
| -€124.50K
|
| Elanco Animal Health Incorporated
|
52
/ 100
| 16
| 45.8%
| 4.7%
| 3.2%
| €41.37K
|
| Solara Active Pharma Sciences Limited
|
50
/ 100
| 92
| 47.6%
| 16.6%
| 0.0%
| €1.08K
|
| Blum Holdings, Inc.
|
50
/ 100
| 0.99
| 48.8%
| -50.7%
| 24.2%
| €215.49K
|
| Zhuhai Rundu Pharmaceutical Co., Ltd.
|
50
/ 100
| -96
| 36.6%
| -4.3%
| -2.5%
| -€3.24K
|
| Jiangsu Lianhuan Pharmaceutical Co., Ltd.
|
50
/ 100
| -67
| 37.0%
| 2.9%
| -1.1%
| -€4.08K
|
| PT Pyridam Farma Tbk
|
50
/ 100
| -6.6
| 23.2%
| -1.8%
| -6.2%
| -€11.33K
|
| Zhejiang Xinguang Pharmaceutical Co., Ltd.
|
50
/ 100
| 43
| 35.2%
| 24.8%
| 6.5%
| €21.89K
|
| Huadong Medicine Co., Ltd
|
50
/ 100
| 22
| 33.8%
| 10.5%
| 9.4%
| €24.13K
|
| Mangalam Drugs & Organics Limited
|
50
/ 100
| -13
| 42.1%
| 2.0%
| 0.0%
| -€2.15K
|
| Synmosa Biopharma Corporation
|
50
/ 100
| 24
| 43.7%
| 14.1%
| 5.2%
| €40.32K
|
| Nanjing Well Pharmaceutical Group Co.,Ltd.
|
50
/ 100
| 28
| 29.4%
| 12.8%
| 5.6%
| €23.95K
|
| Evotec SE
|
53
/ 100
| -8.7
| 12.9%
| -8.7%
| -8.6%
| -€32.63K
|
| Chongqing Taiji Industry(Group) Co.,Ltd
|
50
/ 100
| -35
| 27.6%
| -0.6%
| -2.5%
| -€3.40K
|
| Guangdong Zhongsheng Pharmaceutical Co., Ltd.
|
50
/ 100
| -59
| 56.6%
| -9.2%
| -3.9%
| -€13.59K
|
| Zhejiang AngLiKang Pharmaceutical CO.,LTD.
|
50
/ 100
| 49
| 39.2%
| 11.6%
| 3.7%
| €10.17K
|
| Jiangsu Yahong Meditech Co Ltd
|
50
/ 100
| -15
| 73.3%
| -146.0%
| -16.7%
| -€112.48K
|
| BioNxt Solutions Inc.
|
50
/ 100
| -10
| -111.3%
| -22,429.9%
| -984.0%
| -€150.11K
|
| Harbin Gloria Pharmaceuticals Co., Ltd
|
50
/ 100
| 23
| 48.4%
| 13.0%
| 9.7%
| €11.53K
|
| Hester Biosciences Limited
|
50
/ 100
| 42
| 63.4%
| 23.8%
| 0.0%
| €5.58K
|
| OptiNose, Inc.
|
50
/ 100
| -3.3
| 90.5%
| -19.3%
| -26.0%
| -€201.93K
|
| Allied Corp.
|
50
/ 100
| -0.14
| -2,027.5%
| -10,491.0%
| -527.1%
| -€62.22K
|
| DongKook Pharmaceutical Co., Ltd.
|
50
/ 100
| 13
| 54.0%
| 10.1%
| 6.0%
| €32.23K
|
| EVIO, Inc.
|
50
/ 100
| 38
| 41.6%
| 31.1%
| 0.0%
| €2.43K
|
| Journey Medical Corporation
|
50
/ 100
| -18
| 67.5%
| -12.2%
| -10.8%
| -€182.86K
|
| Aarti Pharmalabs Limited
|
50
/ 100
| 31
| 47.7%
| 19.2%
| 0.0%
| €12.12K
|
| Pharma Foods International Co., Ltd.
|
50
/ 100
| 118
| 79.5%
| 2.6%
| 0.7%
| €1.94K
|
| Goodness Growth Holdings, Inc.
|
50
/ 100
| -1
| 47.1%
| 2.4%
| -6.4%
| -€93.76K
|
| Jiang Zhong Pharmaceutical Co.,Ltd
|
50
/ 100
| 17
| 62.4%
| 25.4%
| 12.1%
| €24.30K
|
| Red White & Bloom Brands Inc.
|
50
/ 100
| -0.52
| 30.3%
| -18.7%
| -10.7%
| €0.00
|
| Hanall Biopharma Co.,Ltd
|
50
/ 100
| 617
| 53.3%
| 2.6%
| 1.2%
| €4.23K
|
| Siegfried Holding AG
|
50
/ 100
| 16
| 25.8%
| 14.6%
| 14.4%
| €77.58K
|
| HPGC Renmintongtai Pharmaceutical Corporation
|
50
/ 100
| 37
| 7.9%
| 1.7%
| 1.7%
| €5.04K
|
| Guizhou Yibai Pharmaceutical Co., Ltd.
|
50
/ 100
| -14
| 60.2%
| -11.4%
| -6.1%
| -€5.17K
|
| Upexi, Inc.
|
50
/ 100
| -21
| -1.9%
| 93.3%
| -149.4%
| -€301.70K
|
| IDT Australia Limited
|
50
/ 100
| -2.8
| 41.2%
| -33.3%
| -36.5%
| -€49.22K
|
| Mithra Pharmaceuticals SA
|
50
/ 100
| -0.062
| 38.7%
| -96.4%
| -81.4%
| -€863.41K
|
| Collegium Pharmaceutical, Inc.
|
50
/ 100
| 26
| 56.7%
| 18.4%
| 2.3%
| €87.17K
|
| FutureChem Co.,Ltd
|
50
/ 100
| -133
| 17.8%
| -44.5%
| -5.5%
| -€34.99K
|
| Sibannac, Inc.
|
50
/ 100
| -0.91
| 50.0%
| -10,585.2%
| -100.7%
| -€691.88K
|
| Kyongbo Pharmaceutical Co., Ltd
|
50
/ 100
| 322
| 29.0%
| 3.6%
| 0.1%
| €467.56
|
| Phibro Animal Health Corporation
|
50
/ 100
| 21
| 30.9%
| 8.5%
| 3.5%
| €21.35K
|
| Cann American Corp.
|
50
/ 100
| -4.2K
| 23.9%
| -1,809.2%
| -356.1%
| -€533.21
|
| Shandong Shanda Wit Science and Technology Co., Ltd.
|
50
/ 100
| 13
| 83.8%
| 54.9%
| 11.3%
| €35.89K
|
| Blueberries Medical Corp.
|
50
/ 100
| -7.2
| 34.0%
| -312.4%
| -115.1%
| €0.00
|
| Shuttle Pharmaceuticals Holdings, Inc.
|
50
/ 100
| -0.2
| 0.0%
| -203,380.9%
| -220.6%
| -€1.16M
|
| Sumitomo Pharma Co., Ltd.
|
50
/ 100
| 3.4K
| 60.9%
| 12.6%
| 2.6%
| €20.94K
|
| Alar Pharmaceuticals Inc.
|
50
/ 100
| -1.1K
| 66.4%
| -1,193.0%
| -0.7%
| -€17.81K
|
| Mercury Biopharmaceutical Corporation
|
50
/ 100
| -21
| -84.5%
| -1,998.1%
| -36.0%
| -€149.28K
|
| Huapont Life Sciences Co., Ltd.
|
50
/ 100
| -60
| 34.3%
| 1.9%
| -0.5%
| -€1.34K
|
| Veritas Farms, Inc.
|
50
/ 100
| -0.0085
| -220.1%
| -670.6%
| -69.1%
| -€290.32K
|
| Henan Lingrui Pharmaceutical Co., Ltd.
|
50
/ 100
| 17
| 80.6%
| 23.4%
| 13.9%
| €38.37K
|
| Alembic Pharmaceuticals Limited
|
50
/ 100
| 32
| 73.5%
| 20.7%
| 0.0%
| €3.87K
|
| GelStat Corporation
|
50
/ 100
| -0.99
| 67.7%
| -93.5%
| -68.3%
| -€93.59K
|
| MC Endeavors, Inc.
|
50
/ 100
| -44
| 66.6%
| -1.7%
| -751.2%
| -€3.14K
|
| Green Thumb Industries Inc.
|
50
/ 100
| 30
| 51.6%
| 15.7%
| 1.1%
| €5.07K
|
| Global Health Clinics Ltd.
|
50
/ 100
| -0.075
| 88.5%
| -1,315.8%
| -7,280.3%
| €0.00
|
| Guobang Pharma Ltd.
|
50
/ 100
| 14
| 25.6%
| 16.3%
| 8.3%
| €26.47K
|
| Bioray Biotech Co., Ltd
|
50
/ 100
| 50
| 38.6%
| 2.4%
| 2.8%
| €0.00
|
| Zhejiang Tianyu Pharmaceutical Co., Ltd.
|
50
/ 100
| 44
| 37.6%
| 7.4%
| 2.9%
| €4.96K
|
| Wockhardt Limited
|
50
/ 100
| -236
| 56.8%
| 6.2%
| 0.0%
| -€4.91K
|
| PT Tempo Scan Pacific Tbk
|
50
/ 100
| 8.4
| 37.9%
| 11.2%
| 10.4%
| €15.31K
|
| Changchun BCHT Biotechnology Co.
|
50
/ 100
| 251
| 81.5%
| -1.0%
| 0.4%
| €2.05K
|
| Cumberland Pharmaceuticals Inc.
|
50
/ 100
| -29
| 80.4%
| -6.5%
| -4.3%
| -€27.64K
|
| MERCK Kommanditgesellschaft auf Aktien
|
50
/ 100
| 15
| 58.5%
| 18.0%
| 6.0%
| €48.51K
|
| Hygrovest Limited
|
50
/ 100
| -1.6
| -187.5%
| -11,237.6%
| -14.3%
| €0.00
|
| Koa Shoji Holdings Co.,Ltd.
|
50
/ 100
| 8.2
| 32.6%
| 22.6%
| 10.7%
| €69.54K
|
| Aleafia Health Inc.
|
50
/ 100
| -0.17
| 14.3%
| -41.1%
| -77.4%
| -€182.39K
|
| Lantheus Holdings, Inc.
|
51
/ 100
| 21
| 63.7%
| 28.8%
| 12.8%
| €287.77K
|
| Delivra Health Brands Inc.
|
50
/ 100
| -70
| 49.8%
| -9.9%
| -1.6%
| €0.00
|
| Harbin Medisan Pharmaceutical Co., Ltd.
|
50
/ 100
| -27
| 44.9%
| -24.2%
| -5.3%
| -€9.18K
|
| Decibel Cannabis Company Inc.
|
50
/ 100
| 4.8
| 39.5%
| 0.6%
| 6.0%
| €32.69K
|
| Zhejiang NHU Company Ltd.
|
50
/ 100
| 9.2
| 46.1%
| 37.2%
| 16.0%
| €76.87K
|
| JW Holdings Corporation
|
50
/ 100
| 12
| 50.5%
| 17.5%
| 2.0%
| €104.97K
|
| Bukwang Pharmaceutical Co., Ltd.
|
50
/ 100
| 45
| 33.7%
| 5.7%
| 2.2%
| €8.79K
|
| Taiko Pharmaceutical Co.,Ltd.
|
50
/ 100
| 14
| 58.2%
| 10.0%
| 7.0%
| €23.15K
|
| Morepen Laboratories Limited
|
50
/ 100
| 39
| 35.6%
| 9.1%
| 0.0%
| €4.10K
|
| Windlas Biotech Limited
|
50
/ 100
| 30
| 38.1%
| 8.9%
| 0.0%
| €5.38K
|
| Acusphere, Inc.
|
50
/ 100
| -0.0000011
| 100.0%
| 1,837.4%
| -207.8%
| €0.00
|
| Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd
|
50
/ 100
| 393
| 72.9%
| 7.4%
| 1.3%
| €4.55K
|
| WDB coco Co., Ltd.
|
50
/ 100
| 7.3
| 39.0%
| 24.5%
| 16.3%
| €9.99K
|
| Zhejiang Yatai Pharmaceutical Co., Ltd.
|
50
/ 100
| 22
| 30.8%
| 39.0%
| 11.1%
| €30.95K
|
| Ipsen S.A.
|
50
/ 100
| 6.5
| 82.5%
| 20.0%
| 16.5%
| €210.73K
|
| Hainan Poly Pharm. Co., Ltd
|
50
/ 100
| -4.7
| 72.0%
| -0.3%
| -1.7%
| -€8.23K
|
| MediPharm Labs Corp.
|
50
/ 100
| -4.1
| 31.6%
| -19.9%
| -17.6%
| -€33.42K
|
| CannLabs, Inc.
|
50
/ 100
| 0.26
| 52.1%
| 29.6%
| 0.0%
| €8.44K
|
| Medical Developments International Limited
|
50
/ 100
| -1.6
| 37.3%
| -19.1%
| -61.6%
| -€342.72K
|
| YungShin Global Holding Corporation
|
50
/ 100
| 16
| 43.8%
| 16.6%
| 8.1%
| €0.00
|
| Mountain Valley MD Holdings Inc.
|
50
/ 100
| -0.94
| -26.5%
| -5,608.2%
| -272.4%
| €0.00
|
| Innova Captab Limited
|
50
/ 100
| 39
| 35.8%
| 16.0%
| 0.0%
| €7.73K
|
| Dynavax Technologies Corporation
|
55
/ 100
| -23
| 82.8%
| -0.2%
| -5.7%
| -€111.72K
|
| AusCann Group Holdings Ltd
|
50
/ 100
| -1.6
| 23.1%
| -12,896.1%
| -149.0%
| -€229.89K
|
| Tasly Pharmaceutical Group Co., Ltd
|
50
/ 100
| 22
| 67.3%
| 14.5%
| 7.3%
| €12.16K
|
| Bliss GVS Pharma Limited
|
50
/ 100
| 15
| 45.4%
| 19.2%
| 0.0%
| €12.23K
|
| Vetoquinol SA
|
50
/ 100
| 8.1
| 44.1%
| 11.9%
| 14.8%
| €42.52K
|
| SCI Pharmtech, Inc.
|
50
/ 100
| 17
| 25.4%
| 12.4%
| 6.9%
| €65.68K
|
| ODI Pharma AB
|
50
/ 100
| -4.5
| -24.1%
| -175.0%
| -104.8%
| -€551.30K
|
| MJ Holdings, Inc.
|
50
/ 100
| -0.0058
| 101.4%
| 589.3%
| -22.6%
| -€96.03K
|
| ANI Pharmaceuticals, Inc.
|
49
/ 100
| -123
| 57.9%
| 2.0%
| -0.8%
| -€10.55K
|
| OrganiGram Holdings Inc.
|
50
/ 100
| 34
| 33.8%
| -9.3%
| 1.4%
| €4.42K
|
| Fuso Pharmaceutical Industries,Ltd.
|
50
/ 100
| 10
| 26.0%
| 5.0%
| 2.1%
| €7.42K
|
| ProPhase Labs, Inc.
|
50
/ 100
| -0.36
| 60.4%
| -900.0%
| -98.6%
| -€370.48K
|
| Rubicon Organics Inc.
|
50
/ 100
| 117
| 34.7%
| 2.4%
| 0.4%
| €703.01
|
| Boryung Corporation
|
50
/ 100
| 23
| 27.2%
| 6.9%
| 2.4%
| €12.14K
|
| Viatris Inc.
|
51
/ 100
| -2.9
| 36.1%
| -18.4%
| -9.7%
| -€98.97K
|
| FutureWorld Corp.
|
50
/ 100
| -0.5
| 106.8%
| -187.7%
| -0.9%
| -€56.70K
|
| Global Pharmatech, Inc.
|
50
/ 100
| -1.6K
| 10.4%
| -20.7%
| -7.1%
| -€211.38
|
| Luoxin Pharmaceuticals Group Stock Co., Ltd.
|
50
/ 100
| -8.6
| 48.3%
| -24.1%
| -17.0%
| -€24.26K
|
| Excelsior Biopharma Inc.
|
50
/ 100
| -11
| 42.5%
| -13.6%
| -9.4%
| €0.00
|
| Bionoid Pharma Inc.
|
50
/ 100
| -180
| -39.3%
| -117.1%
| -37.8%
| -€4.56K
|
| Korea United Pharm Inc.
|
50
/ 100
| 9.2
| 41.6%
| 18.0%
| 7.0%
| €20.94K
|
| Sangui Biotech International, Inc.
|
50
/ 100
| -0.97
| 100.0%
| -20.5%
| -48.3%
| €0.00
|
| One World Products, Inc.
|
50
/ 100
| -1.1
| 80.0%
| -17,234.0%
| -835.7%
| -€162.21K
|
| MYUNGMOON Pharm co.,Ltd
|
50
/ 100
| 47
| 55.5%
| 4.4%
| 0.4%
| €2.52K
|
| Evoke Pharma, Inc.
|
50
/ 100
| -0.83
| 96.6%
| -41.7%
| -33.5%
| -€1.54M
|
| Takeda Pharmaceutical Company Limited
|
50
/ 100
| 209
| 60.3%
| 6.6%
| 0.2%
| €3.70K
|
| Full Alliance Group, Inc.
|
50
/ 100
| -0.73
| 69.2%
| -63.5%
| -26.7%
| -€420.82K
|
| Ipca Laboratories Limited
|
50
/ 100
| 46
| 62.6%
| 14.8%
| 0.0%
| €4.28K
|
| Honz Pharmaceutical Co., Ltd.
|
50
/ 100
| -13
| 55.1%
| -43.8%
| -10.1%
| -€30.73K
|
| Tilray Brands, Inc.
|
42
/ 100
| -0.2
| 28.7%
| -235.1%
| -102.9%
| -€693.82K
|
| Athenex, Inc.
|
50
/ 100
| -0.023
| 23.0%
| -61.7%
| -50.4%
| -€328.17K
|
| Jamjoom Pharmaceuticals Factory Company
|
50
/ 100
| 27
| 62.2%
| 30.8%
| 20.9%
| €92.36K
|
| Resonate Blends, Inc.
|
50
/ 100
| -0.059
| 67.2%
| -57.1%
| -175.2%
| -€254.77K
|
| Canopy Growth Corporation
|
50
/ 100
| -1.1
| 27.3%
| -29.0%
| -26.2%
| -€233.43K
|
| CKD Bio Corp.
|
50
/ 100
| 70
| 15.3%
| 4.9%
| 0.6%
| €2.13K
|
| JW Pharmaceutical Corporation
|
50
/ 100
| 11
| 46.3%
| 12.3%
| 8.8%
| €28.54K
|
| Foresee Pharmaceuticals Co., Ltd.
|
50
/ 100
| -8.9
| 59.3%
| -248.4%
| -90.7%
| €0.00
|
| Shanghai Shyndec Pharmaceutical Co., Ltd.
|
50
/ 100
| 16
| 34.4%
| 14.5%
| 4.8%
| €9.84K
|
| StateHouse Holdings Inc.
|
50
/ 100
| -0.096
| 47.7%
| -4.4%
| -35.1%
| -€113.26K
|
| Kotra Industries Berhad
|
50
/ 100
| 14
| 60.8%
| 22.3%
| 12.2%
| €13.53K
|
| Rekah Pharmaceutical Industry Ltd.
|
50
/ 100
| -44
| 22.9%
| -1.8%
| -3.2%
| -€8.55K
|
| Maven Brands Inc.
|
50
/ 100
| -0.41
| 874.3%
| 10,364.4%
| -34.2%
| €0.00
|
| Kissei Pharmaceutical Co., Ltd.
|
50
/ 100
| 15
| 49.5%
| 6.4%
| 5.1%
| €38.37K
|
| Zhejiang Hisoar Pharmaceutical Co., Ltd.
|
50
/ 100
| -28
| 25.7%
| -17.3%
| -4.6%
| -€15.57K
|
| Vifor Pharma AG
|
50
/ 100
| 0
| 59.3%
| 11.2%
| 5.8%
| €125.43K
|
| Kilitch Drugs (India) Limited
|
50
/ 100
| 26
| 46.4%
| 14.2%
| 0.0%
| €16.10K
|
| Industry Source Consulting, Inc.
|
50
/ 100
| -0.025
| -672.0%
| -1,414.7%
| -10.5%
| -€291.48K
|
| China Health Industries Holdings, Inc.
|
50
/ 100
| -9.6
| -262.9%
| -1,439.7%
| -33.0%
| -€36.52K
|
| DURECT Corporation
|
50
/ 100
| -5.4
| 53.3%
| 1,395.6%
| -27.9%
| -€142.10K
|
| Xiamen Kingdomway Group Company
|
50
/ 100
| 23
| 40.1%
| 17.8%
| 5.8%
| €27.57K
|
| High Sierra Technologies, Inc.
|
50
/ 100
| -13
| -230.1%
| -24,674.6%
| -12,643.2%
| -€461.65K
|
| Kaken Pharmaceutical Co., Ltd.
|
50
/ 100
| 11
| 61.4%
| 19.0%
| 7.1%
| €60.56K
|
| Beijing Sun-Novo Pharmaceutical Research Co., Ltd.
|
50
/ 100
| 37
| 48.0%
| 14.6%
| 7.2%
| €12.38K
|
| PharmaBlock Sciences (Nanjing), Inc.
|
50
/ 100
| 36
| 32.0%
| 11.8%
| 2.6%
| €9.95K
|
| Pharmigene, Inc.
|
50
/ 100
| -3.4
| 29.1%
| -52.6%
| -17.4%
| -€94.38K
|
| Shaanxi Kanghui Pharmaceutical Co., Ltd.
|
50
/ 100
| -23
| 27.9%
| -28.6%
| -6.5%
| -€15.45K
|
| Hunan Er-Kang Pharmaceutical Co., Ltd
|
50
/ 100
| -23
| 25.1%
| -24.7%
| -5.9%
| -€25.00K
|
| Daito Pharmaceutical Co.,Ltd.
|
50
/ 100
| 15
| 18.3%
| 5.4%
| 2.8%
| €11.20K
|
| Anything Technologies Media, Inc.
|
50
/ 100
| -8.2
| -1,033.7%
| -9,079.7%
| -13.2%
| €0.00
|
| Orient EuroPharma Co., Ltd.
|
50
/ 100
| -14
| 47.6%
| -1.1%
| -2.6%
| €0.00
|
| Lavipharm S.A.
|
50
/ 100
| 15
| 46.1%
| 16.9%
| 8.9%
| €37.58K
|
| CV Sciences, Inc.
|
50
/ 100
| -3.1
| 46.5%
| -7.4%
| -19.5%
| -€28.33K
|
| MedRx Co., Ltd
|
50
/ 100
| -7.3
| 88.3%
| -399.2%
| -60.5%
| -€277.53K
|
| UniPharma Co., Ltd.
|
50
/ 100
| -6.7
| 49.5%
| -37.8%
| -22.4%
| -€59.83K
|
| Apeloa Pharmaceutical Co.,Ltd
|
50
/ 100
| 20
| 24.4%
| 9.6%
| 7.1%
| €14.82K
|
| Jeil Pharma Holdings Inc
|
50
/ 100
| -3.8
| 30.4%
| 2.0%
| -4.2%
| -€588.30K
|
| Cannabis Suisse Corp.
|
50
/ 100
| 5.7
| -5.2%
| -1,407.0%
| 16.3%
| €0.00
|
| Shandong Lukang Pharmaceutical Co.,Ltd.
|
50
/ 100
| 53
| 23.9%
| 4.0%
| 2.1%
| €3.53K
|
| Laurus Labs Limited
|
50
/ 100
| 71
| 56.5%
| 21.5%
| 0.0%
| €8.07K
|
| Silver Spike Investment Corp.
|
50
/ 100
| 46
| 233.7%
| 222.7%
| 5.5%
| €0.00
|
| Hikma Pharmaceuticals PLC
|
50
/ 100
| 9.6
| 43.7%
| 15.6%
| 11.8%
| €59.08K
|
| SFLMaven Corp.
|
50
/ 100
| -0.15
| 1.5%
| -28.8%
| -3,028.5%
| -€1.30M
|
| Zhejiang Huahai Pharmaceutical Co., Ltd.
|
50
/ 100
| 68
| 61.1%
| 7.9%
| 2.2%
| €6.91K
|
| Whan In Pharm Co.,Ltd.
|
50
/ 100
| 11
| 33.4%
| 5.5%
| 3.8%
| €16.50K
|
| Heritage Cannabis Holdings Corp.
|
50
/ 100
| -0.23
| 33.3%
| -27.0%
| -36.0%
| -€6.24M
|
| Embecta Corp.
|
50
/ 100
| 7.1
| 62.8%
| 19.2%
| 7.2%
| €35.56K
|
| Huons Global Co., Ltd.
|
50
/ 100
| 40
| 63.1%
| 11.2%
| 1.1%
| €77.90K
|
| Jeil Pharmaceutical Co.,Ltd
|
50
/ 100
| 38
| 29.5%
| 1.3%
| 1.1%
| €3.10K
|
| Aerie Pharmaceuticals, Inc.
|
50
/ 100
| 0
| 89.0%
| -10.9%
| -9.7%
| -€83.42K
|
| Christina Lake Cannabis Corp.
|
50
/ 100
| 200
| 27.7%
| -3.2%
| 0.2%
| €0.00
|
| Lannett Company, Inc.
|
50
/ 100
| -0.028
| 16.1%
| -18.2%
| -77.4%
| -€394.15K
|
| Trees Corporation
|
50
/ 100
| -0.69
| 42.6%
| -5.1%
| -20.0%
| -€39.16K
|
| InnoPharmax Inc.
|
50
/ 100
| -14
| 38.3%
| -177.0%
| -25.1%
| -€120.91K
|
| Klaria Pharma Holding AB (publ.)
|
50
/ 100
| -1.3
| 100.0%
| -252.4%
| -89.8%
| -€1.03M
|
| Valiant Laboratories Limited
|
50
/ 100
| 4K
| 13.7%
| 0.5%
| 0.0%
| €159.39
|
| Dong-A Socio Holdings Co., Ltd.
|
50
/ 100
| 8.6
| 31.2%
| 6.7%
| 4.3%
| €9.56K
|
| Upper Street Marketing Inc.
|
50
/ 100
| -0.014
| -1,074.6%
| -9,264.4%
| -14.4%
| -€3.08K
|
| Shandong Buchang Pharmaceuticals Co., Ltd.
|
50
/ 100
| -114
| 62.4%
| 1.0%
| -0.8%
| -€2.30K
|
| Target Group Inc.
|
50
/ 100
| -2.1
| 57.2%
| 16.8%
| -14.7%
| -€12.37K
|
| Daewon Pharmaceutical Co., Ltd.
|
50
/ 100
| 36
| 46.6%
| 3.7%
| 1.4%
| €3.79K
|
| Faes Farma, S.A.
|
50
/ 100
| 11
| 56.9%
| 35.7%
| 12.7%
| €71.45K
|
| Digital Utilities Ventures, Inc.
|
50
/ 100
| 288
| 56.7%
| -114.0%
| 1.5%
| €0.00
|
| Assertio Holdings, Inc.
|
50
/ 100
| -1.5
| 67.9%
| -32.3%
| -15.6%
| -€633.15K
|
| Simply Better Brands Corp.
|
50
/ 100
| -86
| 30.5%
| -11.1%
| -3.0%
| -€14.83K
|
| Huaren Pharmaceutical Co., Ltd.
|
50
/ 100
| -2.8
| 33.3%
| -111.7%
| -41.5%
| -€63.82K
|
| Bausch Health Companies Inc.
|
50
/ 100
| 3.9
| 81.5%
| 23.0%
| 1.4%
| €15.00K
|
| Beijing SL Pharmaceutical Co., Ltd.
|
50
/ 100
| 450
| 59.0%
| 0.2%
| 0.3%
| €2.47K
|
| N4 Pharma Plc
|
50
/ 100
| -0.019
| 61.4%
| -24,979.2%
| -120.4%
| -€508.21K
|
| Creso Pharma Limited
|
50
/ 100
| -2.7
| 55.7%
| -699.9%
| -38.9%
| €0.00
|
| BioQuest Corp.
|
50
/ 100
| -9.4
| 29.0%
| -541.3%
| -66.1%
| -€157.58K
|
| China Pharma Holdings, Inc.
|
50
/ 100
| -0.0000066
| -12.0%
| -66.8%
| -5,706,399.2%
| -€3.01B
|
| Shilpa Medicare Limited
|
50
/ 100
| 85
| 69.8%
| 16.7%
| 0.0%
| €10.51K
|
| Auxly Cannabis Group Inc.
|
50
/ 100
| 4
| 54.5%
| 16.0%
| 10.9%
| €44.98K
|
| PhytoHealth Corporation
|
50
/ 100
| -45
| 38.6%
| -120.0%
| -2.8%
| -€21.65K
|
| PT Phapros, Tbk
|
50
/ 100
| -1.2
| 39.6%
| -36.3%
| -16.0%
| -€8.66K
|
| Morishita Jintan Co., Ltd.
|
50
/ 100
| 16
| 45.4%
| 4.9%
| 3.1%
| €8.52K
|
| Zhejiang Shapuaisi Pharmaceutical Co.,Ltd.
|
50
/ 100
| -37
| 53.5%
| -18.4%
| -3.7%
| -€6.74K
|
| Pharmagreen Biotech Inc.
|
50
/ 100
| -3.1
| -22.9%
| -9,102.6%
| -242.6%
| €0.00
|
| Hana Pharm Co., Ltd.
|
50
/ 100
| 11
| 61.8%
| 10.6%
| 5.1%
| €15.96K
|
| Laboratorio Reig Jofre, S.A.
|
50
/ 100
| 29
| 58.7%
| 2.4%
| 2.5%
| €6.66K
|
| Shenzhen Weiguang Biological Products Co., Ltd.
|
50
/ 100
| 29
| 42.3%
| 23.3%
| 6.7%
| €32.32K
|
| Aida Pharmaceuticals, Inc.
|
50
/ 100
| -0.0026
| 55.7%
| 31.6%
| -2.8%
| -€3.99K
|
| Shanghai Kaibao Pharmaceutical CO.,Ltd
|
50
/ 100
| 19
| 81.1%
| 32.4%
| 7.0%
| €31.66K
|
| Crescita Therapeutics Inc.
|
50
/ 100
| -7.1
| 52.0%
| -9.5%
| -6.1%
| €0.00
|
| AptaBio Therapeutics Inc.
|
50
/ 100
| -8.3
| 20.7%
| -620.1%
| -36.1%
| -€460.56K
|
| Wakamoto Pharmaceutical Co.,Ltd.
|
50
/ 100
| -60
| 47.0%
| -1.9%
| -1.2%
| -€2.43K
|
| Adamas Pharmaceuticals, Inc.
|
50
/ 100
| 0
| 97.6%
| -44.6%
| -43.6%
| -€389.88K
|
| Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.
|
50
/ 100
| -37
| 87.6%
| -8.4%
| -1.0%
| -€3.30K
|
| ChengDu ShengNuo Biotec Co.,Ltd.
|
50
/ 100
| 47
| 56.8%
| 24.5%
| 6.7%
| €12.61K
|
| Tikun Olam-Cannbit Pharmaceuticals Ltd
|
50
/ 100
| -3.1
| 18.7%
| 131.4%
| -512.8%
| -€565.70K
|
| ViaDerma, Inc.
|
50
/ 100
| -0.8
| 100.0%
| -12.1%
| -3.8%
| €0.00
|
| Together Pharma Ltd
|
50
/ 100
| -32
| 15.7%
| 0.3%
| -4.3%
| -€8.82K
|
| Cronos Group Inc.
|
50
/ 100
| 15
| 43.4%
| -16.1%
| 3.1%
| €67.48K
|
| Zhejiang Garden Bio-chemical High-tech Co., Ltd.
|
50
/ 100
| 26
| 56.2%
| 28.3%
| 5.1%
| €38.85K
|
| Zhejiang Jiuzhou Pharmaceutical Co., Ltd
|
50
/ 100
| 22
| 35.0%
| 15.8%
| 6.0%
| €15.95K
|
| Provexis plc
|
50
/ 100
| -0.13
| 38.9%
| -39.1%
| -118.5%
| -€557.33K
|
| Lincoln Pharmaceuticals Limited
|
50
/ 100
| 14
| 53.9%
| 14.2%
| 0.0%
| €4.88K
|
| Genex Pharmaceutical, Inc.
|
50
/ 100
| 0.0052
| 88.8%
| 14.4%
| 4.0%
| €3.42K
|
| Toho Holdings Co., Ltd.
|
50
/ 100
| 13
| 8.0%
| 1.3%
| 2.9%
| €15.58K
|
| Tus-Pharmaceutical Group Co., Ltd.
|
50
/ 100
| -21
| 46.8%
| -44.7%
| -11.8%
| -€10.98K
|
| Dezhan Healthcare Company Limited
|
50
/ 100
| -82
| 60.5%
| -32.7%
| -1.7%
| -€10.85K
|
| Solasia Pharma K.K.
|
50
/ 100
| -3.7
| 62.8%
| -640.6%
| -101.1%
| -€452.07K
|
| PetIQ, Inc.
|
50
/ 100
| 70
| 24.6%
| 5.7%
| 1.5%
| €10.10K
|
| Jiangsu Nhwa Pharmaceutical Co., Ltd.
|
50
/ 100
| 18
| 75.3%
| 23.0%
| 13.5%
| €25.20K
|
| PT Indofarma Tbk
|
50
/ 100
| -1.3
| -21.9%
| -115.4%
| -53.2%
| -€19.94K
|
| Mercanto Holdings Inc.
|
50
/ 100
| -6.6
| 25.2%
| -13.1%
| -32.6%
| €0.00
|
| Ascendis Health Limited
|
50
/ 100
| 190
| 35.9%
| 6.6%
| 6.8%
| €835.26
|
| Blau Farmacêutica S.A.
|
50
/ 100
| 8.2
| 39.6%
| 24.0%
| 8.1%
| €23.56K
|
| Par Drugs and Chemicals Limited
|
50
/ 100
| 8.5
| 57.6%
| 23.3%
| 0.0%
| €11.05K
|
| Rafarma Pharmaceuticals, Inc.
|
50
/ 100
| 21
| 7.9%
| 5.0%
| 2.5%
| €0.00
|
| Guangxi Wuzhou Zhongheng Group Co.,Ltd
|
50
/ 100
| -24
| 35.9%
| -23.1%
| -3.3%
| -€15.29K
|
| Adastra Holdings Ltd.
|
50
/ 100
| -0.14
| 35.7%
| -9.1%
| -85.1%
| €0.00
|
| Planet Based Foods Global Inc.
|
50
/ 100
| 5.3
| 47.3%
| 581.1%
| 655.0%
| €0.00
|
| China Resources Pharmaceutical Group Limited
|
50
/ 100
| 4.7
| 15.8%
| 4.5%
| 2.3%
| €10.77K
|
| Herborium Group, Inc.
|
50
/ 100
| -3.8K
| 49.9%
| -2.4%
| -11.2%
| -€10.89K
|
| Jilin Aodong Pharmaceutical Group Co., Ltd.
|
50
/ 100
| 7.4
| 45.7%
| 44.8%
| 7.4%
| €54.26K
|
| Antisense Therapeutics Limited
|
50
/ 100
| -0.78
| 97.7%
| -788.3%
| -109.1%
| -€998.37K
|
| BC Craft Supply Co. Ltd.
|
50
/ 100
| -0.000035
| 2.4%
| -437.8%
| -4,046.2%
| €0.00
|
| Deva Holding A.S.
|
50
/ 100
| 122
| 36.4%
| 11.2%
| 0.3%
| €597.46
|
| Prince Pharmaceutical Co., Ltd.
|
50
/ 100
| -34
| 13.2%
| -2.0%
| -2.6%
| -€4.68K
|
| Fujian Cosunter Pharmaceutical Co., Ltd.
|
50
/ 100
| -29
| 62.5%
| -45.4%
| -13.0%
| -€26.37K
|
| PT Industri Jamu dan Farmasi Sido Muncul Tbk
|
50
/ 100
| 13
| 58.0%
| 37.9%
| 31.9%
| €16.60K
|
| Univec, Inc.
|
50
/ 100
| -4.6
| -6.9%
| -2,266.6%
| -3,508.0%
| -€352.91K
|
| Aeolus Pharmaceuticals, Inc.
|
50
/ 100
| -0.0037
| -223.2%
| -531.0%
| -515.6%
| -€878.16K
|
| Endexx Corporation
|
50
/ 100
| -0.17
| 57.6%
| -5.9%
| -826.4%
| -€1.09M
|
| Aarey Drugs & Pharmaceuticals Limited
|
50
/ 100
| 37
| 3.1%
| 0.6%
| 0.0%
| €0.00
|
| Changchun High-Tech Industries (Group) Inc.
|
50
/ 100
| 46
| 84.5%
| 10.1%
| 3.0%
| €10.08K
|
| American Green, Inc.
|
50
/ 100
| -0.13
| 8.4%
| -18.9%
| -117.8%
| €0.00
|
| Sonoma Pharmaceuticals, Inc.
|
50
/ 100
| -1.5
| 37.7%
| -24.4%
| -24.4%
| -€305.02K
|
| IM Cannabis Corp.
|
50
/ 100
| -1.5
| 15.6%
| -50.4%
| -27.0%
| -€69.25K
|
| Toleranzia AB
|
50
/ 100
| -9.5
| 302.9%
| -178.4%
| -7.2%
| -€120.90K
|
| Eisai Co., Ltd.
|
50
/ 100
| 24
| 78.3%
| 6.8%
| 3.4%
| €24.61K
|
| Cannabis Global, Inc.
|
50
/ 100
| -0.23
| 18.6%
| -89.7%
| -27.7%
| -€70.12K
|
| Betta Pharmaceuticals Co., Ltd.
|
50
/ 100
| 90
| 78.8%
| 10.7%
| 3.1%
| €18.77K
|
| Targeted Medical Pharma, Inc.
|
50
/ 100
| -0.00099
| 60.2%
| -38.6%
| -125.4%
| -€87.05K
|
| Bakhu Holdings, Corp.
|
50
/ 100
| 8.9
| 157.3%
| -271.0%
| 130.1%
| €289.89K
|
| Nippon Chemiphar Co., Ltd.
|
50
/ 100
| 14
| 27.2%
| 2.6%
| 0.7%
| €2.46K
|
| Dong-E-E-Jiao Co.,Ltd.
|
50
/ 100
| 21
| 72.3%
| 31.3%
| 12.8%
| €48.51K
|
| Shenzhen Neptunus Bioengineering Co., Ltd.
|
50
/ 100
| -5.6
| 8.9%
| -3.7%
| -4.5%
| -€16.21K
|
| Gufic Biosciences Limited
|
50
/ 100
| 60
| 49.5%
| 12.8%
| 0.0%
| €3.95K
|
| Ginwa Enterprise (Group) Inc.
|
50
/ 100
| 35
| 77.3%
| 6.7%
| 4.0%
| €16.17K
|
| Stenocare A/S
|
50
/ 100
| -0.76
| -375.1%
| -988.0%
| -339.2%
| -€488.28K
|
| Hengkang Medical Group Co., Ltd.
|
50
/ 100
| 337
| 30.1%
| 2.6%
| 0.4%
| €365.64
|
| Boditech Med Inc.
|
50
/ 100
| 13
| 58.5%
| 18.9%
| 9.8%
| €31.86K
|
| Alliance Pharma plc
|
50
/ 100
| -0.08
| 54.0%
| 19.3%
| -11.9%
| -€172.95K
|
| Organogenesis Holdings Inc.
|
49
/ 100
| -38
| 73.0%
| -5.3%
| -2.4%
| -€10.84K
|
| CMG Pharmaceutical Co., Ltd.
|
50
/ 100
| -18
| 52.5%
| -5.6%
| -5.9%
| -€38.59K
|
| Esperion Therapeutics, Inc.
|
50
/ 100
| -2.5
| 56.2%
| -7.1%
| -26.9%
| -€276.30K
|
| Piramal Enterprises Limited
|
50
/ 100
| 46
| 86.9%
| 77.1%
| 0.0%
| €4.03K
|
| DMK Pharmaceuticals Corporation
|
50
/ 100
| -0.000046
| -52.6%
| -519.4%
| -248.2%
| -€1.73M
|
| Emergent Health Corp
|
50
/ 100
| -0.013
| 51.4%
| -115.4%
| -308.1%
| -€92.15K
|
| BioGaia AB (publ)
|
50
/ 100
| 336
| 72.5%
| 24.3%
| 20.0%
| €116.87K
|
| Yungjin Pharm. Co., Ltd.
|
50
/ 100
| -4.6K
| 31.7%
| 2.9%
| -0.0%
| -€90.75
|
| Lords & Company Worldwide Holdings Inc.
|
50
/ 100
| -51
| 131.9%
| 94.4%
| -82.4%
| €0.00
|
| Epsilon Healthcare Limited
|
50
/ 100
| -1.2
| 9.8%
| -51.7%
| -46.2%
| €0.00
|
| Jianmin Pharmaceutical Group Co.,Ltd.
|
50
/ 100
| 18
| 57.0%
| 11.2%
| 7.9%
| €16.70K
|
| Guizhou Xinbang Pharmaceutical Co., Ltd.
|
50
/ 100
| 84
| 16.4%
| 3.9%
| 0.9%
| €1.85K
|
| TILT Holdings Inc.
|
50
/ 100
| -0.025
| 16.9%
| -61.5%
| -57.4%
| -€233.23K
|
| Molecule Holdings Inc.
|
50
/ 100
| -0.13
| -25.3%
| -137.3%
| -121.3%
| €0.00
|
| Ecofibre Limited
|
50
/ 100
| -0.087
| 9.1%
| -52.8%
| -145.4%
| €0.00
|
| Lupin Limited
|
50
/ 100
| 25
| 64.8%
| 36.4%
| 0.0%
| €18.35K
|
| Charlotte's Web Holdings, Inc.
|
50
/ 100
| -0.48
| 44.3%
| -40.9%
| -26.6%
| -€166.13K
|
| Hyundai Pharmaceutical Co., Ltd.
|
50
/ 100
| -47
| 41.5%
| -1.0%
| -1.2%
| -€3.03K
|
| Nextage Therapeutics Ltd
|
50
/ 100
| -37
| 23.4%
| -576.1%
| -2,028.9%
| -€45.62K
|
| 1CM Inc.
|
50
/ 100
| 17
| 20.6%
| 4.1%
| 4.2%
| €0.00
|
| 4Front Ventures Corp.
|
50
/ 100
| -0.11
| 35.6%
| -27.5%
| -13.1%
| -€83.51K
|
| Kukje Pharma Co., Ltd.
|
50
/ 100
| 16
| 53.6%
| 5.0%
| 3.7%
| €15.41K
|
| TransGlobal Assets Inc.
|
50
/ 100
| -0.11
| 50.1%
| -567.4%
| -77.1%
| -€231.59K
|
| Brooks Laboratories Limited
|
50
/ 100
| -911
| 31.8%
| 5.6%
| 0.0%
| -€132.72
|
| Haemato AG
|
50
/ 100
| 11
| 6.3%
| 3.4%
| 5.4%
| €131.18K
|
| Nanjing Hicin Pharmaceutical Co., Ltd.
|
50
/ 100
| 110
| 84.2%
| 7.8%
| 3.0%
| €9.80K
|
| Sandoz Group AG
|
49
/ 100
| 75
| 46.3%
| 11.7%
| 1.4%
| €12.08K
|
| Newbury Pharmaceuticals AB (publ)
|
50
/ 100
| -4.7
| 48.4%
| -29.1%
| -15.3%
| -€204.10K
|
| Zhejiang Xianju Pharmaceutical Co.,Ltd.
|
50
/ 100
| 26
| 61.8%
| 16.5%
| 5.0%
| €13.53K
|
| Kamada Ltd.
|
50
/ 100
| 84
| 43.6%
| 14.9%
| 5.2%
| €38.84K
|
| Cann Global Limited
|
50
/ 100
| -965
| -86.1%
| -1,083.8%
| 0.0%
| €0.00
|
| Ilyang Pharmaceutical Co.,Ltd
|
50
/ 100
| 21
| 34.2%
| 4.3%
| 2.5%
| €10.35K
|
| Teva Pharmaceutical Industries Limited
|
52
/ 100
| -123
| 49.6%
| 5.4%
| -0.4%
| -€3.66K
|
| Emergent BioSolutions Inc.
|
50
/ 100
| 4.8
| 49.9%
| 15.1%
| 5.2%
| €72.36K
|
| SymBio Pharmaceuticals Limited
|
50
/ 100
| -305
| 75.7%
| -200.1%
| -93.8%
| -€223.56K
|
| China Shineway Pharmaceutical Group Limited
|
50
/ 100
| 23
| 74.8%
| 19.9%
| 17.7%
| €63.80K
|
| Cresco Labs Inc.
|
50
/ 100
| -2.8
| 49.5%
| 11.0%
| -3.4%
| -€13.51K
|
| CordovaCann Corp.
|
50
/ 100
| -1.6
| 25.6%
| -8.3%
| -55.8%
| €0.00
|
| Amphastar Pharmaceuticals, Inc.
|
50
/ 100
| 9.1
| 50.0%
| 25.2%
| 8.3%
| €56.99K
|
| Nextleaf Solutions Ltd.
|
50
/ 100
| 17
| 38.3%
| -6.1%
| 6.9%
| €15.00K
|
| CLS Holdings USA, Inc.
|
50
/ 100
| 13
| 41.7%
| -8.7%
| 6.6%
| €4.94K
|
| Bio Essence Corporation
|
50
/ 100
| -44
| 69.3%
| -22.2%
| -87.0%
| -€68.83K
|
| Jiangxi Synergy Pharmaceutical Co., Ltd.
|
50
/ 100
| 36
| 30.7%
| 12.3%
| 2.9%
| €8.42K
|
| International Isotopes Inc.
|
50
/ 100
| 246
| 46.3%
| 1.7%
| 0.7%
| €2.57K
|
| Hikal Limited
|
50
/ 100
| 73
| 54.1%
| 17.9%
| 0.0%
| €2.93K
|
| Allied Biotech Corporation
|
50
/ 100
| 35
| 34.9%
| 13.9%
| 2.1%
| €0.00
|
| Nichi-Iko Pharmaceutical Co., Ltd.
|
50
/ 100
| 0.0068
| 20.2%
| 4.1%
| 1.4%
| €755.90K
|
| Neuland Laboratories Limited
|
50
/ 100
| 97
| 48.1%
| 12.4%
| 0.0%
| €10.22K
|
| Jinghua Pharmaceutical Group Co., Ltd.
|
50
/ 100
| 28
| 51.8%
| 20.5%
| 6.4%
| €18.28K
|
| Incannex Healthcare Limited
|
50
/ 100
| -0.79
| 100.0%
| -2,172.3%
| -27.4%
| -€1.54M
|
| Sky Century Investment, Inc.
|
50
/ 100
| -4.4
| -33.0%
| -248.1%
| -90.1%
| -€96.16K
|
| Bright Green Corporation
|
50
/ 100
| -0.8
| -415.0%
| -6,877.0%
| -56.6%
| -€1.55M
|
| Anxo Pharmaceutical Co., Ltd.
|
50
/ 100
| -24
| 37.4%
| 1.1%
| -3.0%
| €0.00
|
| Trulieve Cannabis Corp.
|
50
/ 100
| -3.1
| 61.3%
| 7.4%
| -5.7%
| -€23.83K
|
| Torrent Pharmaceuticals Limited
|
50
/ 100
| 55
| 69.4%
| 32.4%
| 0.0%
| €12.14K
|
| Juva Life Inc.
|
50
/ 100
| -0.00018
| 19.3%
| -49.5%
| -35.4%
| €0.00
|
| Avant Brands Inc.
|
50
/ 100
| -0.39
| 1.8%
| -29.0%
| -40.3%
| -€72.83K
|
| Lotus Pharmaceutical Co., Ltd.
|
50
/ 100
| 12
| 59.9%
| 33.2%
| 12.7%
| €121.64K
|
| Jinhe Biotechnology Co. Ltd.
|
50
/ 100
| 33
| 34.1%
| 5.8%
| 2.5%
| €7.71K
|
| Fuan Pharmaceutical (Group) Co., Ltd.
|
50
/ 100
| 36
| 40.4%
| 5.3%
| 2.4%
| €5.33K
|
| Captor Capital Corp.
|
50
/ 100
| -0.064
| 38.9%
| 200.2%
| -156.3%
| -€186.84K
|
| OMID Holdings, Inc.
|
50
/ 100
| -1.5
| -138.2%
| -275.1%
| -125.0%
| -€112.94K
|
| Cosmos Health Inc.
|
50
/ 100
| -0.94
| 9.8%
| -26.7%
| -24.9%
| -€88.52K
|
| Panaxia Labs Israel Ltd
|
50
/ 100
| -338
| -29.7%
| -96.5%
| -255.5%
| -€358.51K
|
| Cisen Pharmaceutical Co., Ltd.
|
50
/ 100
| 15
| 55.7%
| 14.8%
| 6.1%
| €16.69K
|
| Genomma Lab Internacional, S.A.B. de C.V.
|
50
/ 100
| 11
| 63.4%
| 21.9%
| 8.2%
| €58.41K
|
| Medicine Man Technologies, Inc.
|
50
/ 100
| -0.027
| 32.2%
| -6.2%
| -17.6%
| -€70.24K
|
| Western Sierra Resource Corporation
|
50
/ 100
| 0.043
| 30.0%
| 29.4%
| 0.0%
| €352.37K
|
| Samjin Pharmaceuticals Co., Ltd.
|
50
/ 100
| 12
| 41.9%
| 10.0%
| 4.6%
| €19.72K
|
| Samil Pharmaceutical Co.,Ltd
|
50
/ 100
| -12
| 36.5%
| -5.3%
| -5.3%
| -€19.82K
|
| Yunnan Baiyao Group Co.,Ltd
|
50
/ 100
| 19
| 29.1%
| 15.0%
| 9.7%
| €68.04K
|
| Nanexa AB (publ)
|
50
/ 100
| -9.2
| 232.3%
| -181.6%
| -24.5%
| -€217.47K
|
| Biostar Pharmaceuticals, Inc.
|
50
/ 100
| 0.00028
| -11.6%
| 876.7%
| 2.3%
| €4.01K
|
| MGC Pharmaceuticals Limited
|
50
/ 100
| -0.45
| 23.4%
| -448.3%
| -235.4%
| €0.00
|
| Zhejiang Starry Pharmaceutical Co.,Ltd.
|
50
/ 100
| -104
| 18.7%
| -1.2%
| -0.7%
| -€2.82K
|
| SOHM, Inc.
|
50
/ 100
| -2.1
| 70.9%
| -63.8%
| -12.8%
| -€3.60K
|
| Joincare Pharmaceutical Group Industry Co.,Ltd.
|
50
/ 100
| 16
| 62.6%
| 23.3%
| 3.8%
| €11.56K
|
| Wuhan Hiteck Biological Pharma Co.,Ltd
|
50
/ 100
| -19
| 40.2%
| -32.4%
| -7.1%
| -€14.99K
|
| Fuji Pharma Co., Ltd.
|
50
/ 100
| 11
| 40.2%
| 10.1%
| 3.3%
| €10.20K
|
| Optimind Pharma Corp.
|
50
/ 100
| -0.61
| 87.1%
| -291.8%
| -420.4%
| €0.00
|
| New Leaf Ventures Inc
|
50
/ 100
| -0.19
| 79.2%
| -349.4%
| -120.8%
| €0.00
|
| PharmaCielo Ltd.
|
50
/ 100
| -1.1
| 19.5%
| -112.1%
| -49.7%
| -€21.20K
|
| J. B. Chemicals & Pharmaceuticals Limited
|
50
/ 100
| 40
| 55.7%
| 28.7%
| 0.0%
| €12.29K
|
| 4Cable TV International, Inc.
|
50
/ 100
| -11
| 35.4%
| -36.2%
| -0.5%
| -€4.91K
|
| Ildong Pharmaceutical Co., Ltd.
|
50
/ 100
| -91
| 37.8%
| 2.9%
| -0.7%
| -€2.20K
|
| Vext Science, Inc.
|
50
/ 100
| -1.1
| 30.0%
| -15.4%
| -12.4%
| -€81.95K
|
| Pure Extracts Technologies Corp.
|
50
/ 100
| -0.64
| 8.6%
| -105.6%
| 0.0%
| €0.00
|
| Baotou Dongbao Bio-Tech Co.,Ltd
|
50
/ 100
| 49
| 23.8%
| 9.7%
| 2.7%
| €5.74K
|
| Zhongzhu Healthcare Holding Co.,Ltd
|
50
/ 100
| -6
| 11.7%
| -101.1%
| -27.2%
| -€54.71K
|
| Petros Pharmaceuticals, Inc.
|
50
/ 100
| -0.11
| 76.0%
| -639.9%
| -112.5%
| -€396.65K
|
| Handa Pharmaceuticals, Inc.
|
50
/ 100
| 35
| 90.7%
| 57.8%
| 13.3%
| €0.00
|
| Caplin Point Laboratories Limited
|
50
/ 100
| 28
| 60.7%
| 34.7%
| 0.0%
| €15.81K
|
| Aion Therapeutic Inc.
|
50
/ 100
| -0.73
| 20.3%
| -107.4%
| -550.9%
| €0.00
|
| Procter & Gamble Health Limited
|
50
/ 100
| 39
| 63.1%
| 28.1%
| 31.6%
| €17.92K
|
| Orient Pharma Co., Ltd.
|
50
/ 100
| 77
| 52.7%
| 12.0%
| 3.1%
| €0.00
|
| Qianjiang Yongan Pharmaceutical Co., Ltd.
|
50
/ 100
| 261
| 15.0%
| 1.2%
| 1.1%
| €3.32K
|
| China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.
|
50
/ 100
| 19
| 52.5%
| 13.0%
| 4.9%
| €16.73K
|
| Gold River Productions, Inc.
|
50
/ 100
| -0.062
| -189.5%
| -3,502.7%
| -234.6%
| -€362.43K
|
| SIGA Technologies, Inc.
|
50
/ 100
| 5.5
| 73.1%
| 56.3%
| 34.9%
| €1.53M
|
| InnoCan Pharma Corporation
|
50
/ 100
| -17
| 88.5%
| 1.1%
| -14.3%
| -€122.93K
|
| Sawai Group Holdings Co., Ltd.
|
50
/ 100
| 17
| 29.8%
| 10.8%
| 3.5%
| €19.55K
|
| Wuhan General Group (China), Inc.
|
50
/ 100
| -0.00065
| 45.5%
| -1,831.8%
| -3,881.7%
| -€9.10K
|
| Aquestive Therapeutics, Inc.
|
50
/ 100
| -5.2
| 61.1%
| -119.2%
| -69.4%
| -€393.00K
|
| Bespoke Extracts, Inc.
|
50
/ 100
| -0.39
| 34.5%
| -796.1%
| -677.1%
| -€1.30M
|
| Suheung Co., Ltd.
|
50
/ 100
| 5.2
| 16.6%
| 6.2%
| 4.0%
| €32.70K
|
| Stemtech Corporation
|
50
/ 100
| -1.3
| 75.9%
| -56.0%
| -85.6%
| -€2.84M
|
| VIVO Cannabis Inc.
|
50
/ 100
| -0.19
| 17.1%
| -15.4%
| -106.6%
| -€194.12K
|
| Lotus Ventures Inc.
|
50
/ 100
| -0.45
| -6.9%
| -80.6%
| -14.4%
| €0.00
|
| RLS Global AB (publ)
|
50
/ 100
| -1.2
| -4,174.4%
| -3,461.6%
| -123.3%
| -€294.12K
|
| Venus Remedies Limited
|
50
/ 100
| 11
| 33.1%
| 5.9%
| 0.0%
| €4.31K
|
| Guardion Health Sciences, Inc.
|
50
/ 100
| 0.68
| 43.0%
| -41.4%
| 41.7%
| €607.74K
|
| Galexxy Holdings, Inc.
|
50
/ 100
| -0.45
| -15.0%
| -1,732.8%
| -4,022.5%
| -€1.28M
|
| SES Solar Inc.
|
50
/ 100
| 0.016
| 29.2%
| 3.2%
| 2.3%
| €97.56K
|
| Aurobindo Pharma Limited
|
50
/ 100
| 20
| 58.4%
| 23.3%
| 0.0%
| €12.42K
|
| ECS Botanics Holdings Ltd
|
50
/ 100
| -3.4
| 18.9%
| -12.8%
| -11.3%
| -€9.89K
|
| Vita Life Sciences Limited
|
50
/ 100
| 6
| 59.3%
| 15.5%
| 25.1%
| €0.00
|
| Swedish Orphan Biovitrum AB (publ)
|
50
/ 100
| 7.7K
| 51.3%
| 24.6%
| 0.0%
| €626.53
|
| China Resources Double-Crane Pharmaceutical Co.,Ltd.
|
50
/ 100
| 13
| 57.9%
| 16.4%
| 9.3%
| €14.30K
|
| Anhui Huangshan Capsule Co., Ltd.
|
50
/ 100
| 38
| 28.1%
| 13.3%
| 5.2%
| €10.30K
|
| Indivior PLC
|
50
/ 100
| 0.18
| 84.0%
| 20.3%
| 8.8%
| €106.63K
|
| Easywell Biomedicals, Inc.
|
50
/ 100
| -73
| 50.7%
| -9.5%
| -6.4%
| €0.00
|
| CanadaBis Capital Inc.
|
50
/ 100
| 89
| 46.2%
| 2.6%
| 0.3%
| €0.00
|
| The BC Bud Corporation
|
50
/ 100
| -4.8
| -12.6%
| 243.1%
| -107.7%
| €0.00
|
| Ubiquitech Software Corp.
|
50
/ 100
| 7.5
| 21.1%
| -5.6%
| 11.8%
| €13.28K
|
| BioSyent Inc.
|
50
/ 100
| 17
| 78.2%
| 26.0%
| 19.0%
| €85.55K
|
| Animalcare Group plc
|
50
/ 100
| 0.057
| 46.8%
| 6.7%
| 21.4%
| €177.45K
|
| Ind-Swift Limited
|
50
/ 100
| 1.5
| 43.0%
| 9.6%
| 0.0%
| €5.82K
|
| TTY Biopharm Company Limited
|
50
/ 100
| 13
| 57.9%
| 26.0%
| 14.8%
| €0.00
|
| TherapeuticsMD, Inc.
|
50
/ 100
| 46
| 89.6%
| -97.1%
| 0.8%
| €259.12K
|
| CanaFarma Hemp Products Corp.
|
50
/ 100
| -0.56
| 1,029.9%
| 2,766.8%
| -542.3%
| €0.00
|
| Bajaj HealthCare Limited
|
50
/ 100
| 38
| 41.9%
| 9.9%
| 0.0%
| €4.01K
|
| Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
|
50
/ 100
| 6.4
| 65.7%
| 76.7%
| 30.9%
| €94.02K
|
| Enorama Pharma AB (publ)
|
50
/ 100
| -1.9
| -65.7%
| -558.6%
| -281.6%
| -€1.29M
|
| Shanghai Jiaoda Onlly Co.,Ltd
|
50
/ 100
| 324
| 29.9%
| 12.2%
| 3.5%
| €3.31K
|
| Medicure Inc.
|
50
/ 100
| -8.2
| 54.0%
| -13.0%
| -4.8%
| -€33.64K
|
| Seach Medical Group Ltd
|
50
/ 100
| 25
| 31.3%
| 7.7%
| 9.4%
| €22.87K
|
| Aequus Pharmaceuticals Inc.
|
50
/ 100
| -0.31
| 52.8%
| -211.6%
| -710.2%
| -€111.91K
|
| Aprogen pharmaceuticals,Inc.
|
50
/ 100
| -0.75
| -38.8%
| -92.0%
| -30.9%
| -€287.79K
|
| Ayurcann Holdings Corp.
|
50
/ 100
| -1.6
| 36.7%
| -9.2%
| -24.8%
| €0.00
|
| ASKA Pharmaceutical Holdings Co.,Ltd.
|
50
/ 100
| 13
| 47.4%
| 7.5%
| 4.9%
| €36.72K
|
| Humanwell Healthcare (Group) Co.,Ltd.
|
50
/ 100
| 25
| 45.3%
| 10.8%
| 3.9%
| €9.83K
|
| Duopharma Biotech Berhad
|
50
/ 100
| 17
| 37.1%
| 13.3%
| 5.4%
| €8.16K
|
| SynBiotic SE
|
50
/ 100
| -27
| 2.2%
| -1,471.7%
| -1.2%
| -€12.47K
|
| Mankind Pharma Limited
|
50
/ 100
| 52
| 65.3%
| 27.0%
| 0.0%
| €9.23K
|
| NATCO Pharma Limited
|
50
/ 100
| 9.8
| 77.2%
| 39.0%
| 0.0%
| €40.28K
|
| Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
|
50
/ 100
| 20
| 47.7%
| 11.3%
| 2.8%
| €9.83K
|
